Multiple	O
Oct2	B-protein
isoforms	I-protein
are	O
generated	O
by	O
alternative	O
splicing	O
.	O

The	O
interaction	O
of	O
the	O
Oct2	B-protein
transcription	I-protein
factor	I-protein
with	O
the	O
cognate	B-DNA
octamer	I-DNA
motif	I-DNA
ATGCAAAT	O
is	O
a	O
critical	O
determinant	O
of	O
the	O
lymphoid-specific	O
expression	O
of	O
immunoglobulin	B-DNA
genes	I-DNA
.	O

Ectopic	O
expression	O
of	O
cloned	B-DNA
Oct2	I-DNA
cDNA	I-DNA
was	O
shown	O
to	O
be	O
sufficient	O
to	O
reconstitute	O
at	O
least	O
some	O
aspects	O
of	O
this	O
regulation	O
in	O
non-lymphoid	B-cell_type
cells	I-cell_type
.	O

We	O
describe	O
the	O
isolation	O
and	O
characterization	O
of	O
multiple	B-DNA
cDNAs	I-DNA
encoding	O
mouse	B-protein
Oct2	I-protein
from	O
a	O
mature	B-cell_line
B-cell	I-cell_line
line	I-cell_line
and	O
we	O
show	O
that	O
a	O
variety	O
of	O
isoforms	O
of	O
this	O
transcription	B-protein
factor	I-protein
is	O
generated	O
from	O
a	O
single	O
gene	O
by	O
an	O
alternative	O
splicing	O
mechanism	O
.	O

All	O
the	O
isoforms	B-protein
retain	O
the	O
previously	O
characterized	O
POU-domain	O
and	O
are	O
therefore	O
able	O
to	O
bind	O
to	O
the	O
octamer	B-DNA
motif	I-DNA
.	O

Different	O
amounts	O
of	O
the	O
various	O
isoforms	B-protein
are	O
present	O
within	O
the	O
same	O
B-cell	B-cell_type
regardless	O
of	O
the	O
developmental	O
stage	O
of	O
B-cell	B-cell_type
differentiation	O
and	O
at	O
least	O
some	O
of	O
the	O
isoforms	B-protein
are	O
conserved	O
between	O
mouse	O
and	O
humans	O
.	O

In	O
cotransfection	O
experiments	O
we	O
show	O
that	O
all	O
the	O
isoforms	B-protein
are	O
able	O
to	O
activate	O
an	O
octamer	B-DNA
containing	O
promoter	B-DNA
element	I-DNA
in	O
fibroblasts	O
revealing	O
an	O
unexpected	O
functional	O
redundancy	O
.	O

Finally	O
,	O
we	O
show	O
that	O
one	O
of	O
the	O
isoforms	B-protein
encodes	O
the	O
previously	O
described	O
lymphoid-specific	B-protein
Oct2B	I-protein
protein	I-protein
which	O
has	O
been	O
suggested	O
to	O
be	O
involved	O
in	O
the	O
function	O
of	O
the	O
octamer	B-DNA
motif	I-DNA
in	O
the	O
context	O
of	O
the	O
immunoglobulin	B-DNA
heavy-chain	I-DNA
(	I-DNA
IgH	I-DNA
)	I-DNA
enhancer	I-DNA
.	O

Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

1	NULL
43	NULL
Multiple	NULL
Oct2	NULL
isoforms	NULL
are	NULL
generated	NULL
by	NULL
alternative	NULL
splicing	NULL
Thomas	NULL
Annette	NULL
Priess	NULL
'	NULL
,	NULL
Arnd	NULL
Annweiler	NULL
'	NULL
,	NULL
Stefan	NULL
Zwilling	NULL
'	NULL
and	NULL
Barbara	NULL
Oeler	NULL
'	NULL
Zentrum	NULL
fiir	NULL
Molekulare	NULL
Biologie	NULL
,	NULL
der	NULL
Universitat	NULL
Heidelberg	NULL
(	NULL
ZMBH	NULL
)	NULL
,	NULL
Im	NULL
Neuenheimer	NULL
Feld	NULL
282	NULL
,	NULL
6900	NULL
Heidelberg	NULL
,	NULL
FRG	NULL
and	NULL
Basel	NULL
Institute	NULL
for	NULL
Immunology	NULL
,	NULL
GrenzacherstraBe	NULL
487	NULL
,	NULL
4005	NULL
Basel	NULL
,	NULL
Switzerland	NULL
Received	NULL
October	NULL
8	NULL
,	NULL
1990	NULL
;	NULL
Revised	NULL
and	NULL
Accepted	NULL
December	NULL
3	NULL
,	NULL
1990	NULL
ABSTRACT	NULL
The	NULL
interaction	NULL
of	NULL
the	NULL
Oct2	NULL
transcription	NULL
factor	NULL
with	NULL
the	NULL
cognate	NULL
octamer	NULL
motif	NULL
ATGCAAAT	NULL
is	NULL
a	NULL
critical	NULL
determinant	NULL
of	NULL
the	NULL
lymphoid-specific	NULL
expression	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
.	NULL

Ectopic	NULL
expression	NULL
of	NULL
cloned	NULL
Oct2	NULL
cDNA	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
sufficient	NULL
to	NULL
reconstitute	NULL
at	NULL
least	NULL
some	NULL
aspects	NULL
of	NULL
this	NULL
regulation	NULL
in	NULL
non-lymphoid	NULL
cells	NULL
.	NULL

We	NULL
describe	NULL
the	NULL
isolation	NULL
and	NULL
characterization	NULL
of	NULL
multiple	NULL
cDNAs	NULL
encoding	NULL
mouse	NULL
Oct2	NULL
from	NULL
a	NULL
mature	NULL
B-cell	NULL
line	NULL
and	NULL
we	NULL
show	NULL
that	NULL
a	NULL
variety	NULL
of	NULL
isoforms	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
is	NULL
generated	NULL
from	NULL
a	NULL
single	NULL
gene	NULL
by	NULL
an	NULL
alternative	NULL
splicing	NULL
mechanism	NULL
.	NULL

All	NULL
the	NULL
isoforms	NULL
retain	NULL
the	NULL
previously	NULL
characterized	NULL
POU-domain	NULL
and	NULL
are	NULL
therefore	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
octamer	NULL
motif	NULL
.	NULL

Different	NULL
amounts	NULL
of	NULL
the	NULL
various	NULL
isoforms	NULL
are	NULL
present	NULL
within	NULL
the	NULL
same	NULL
B-cell	NULL
regardless	NULL
of	NULL
the	NULL
developmental	NULL
stage	NULL
of	NULL
B-cell	NULL
differentiation	NULL
and	NULL
at	NULL
least	NULL
some	NULL
of	NULL
the	NULL
isoforms	NULL
are	NULL
conserved	NULL
between	NULL
mouse	NULL
and	NULL
humans	NULL
.	NULL

in	NULL
cotransfection	NULL
experiments	NULL
we	NULL
show	NULL
that	NULL
all	NULL
the	NULL
isoforms	NULL
are	NULL
able	NULL
to	NULL
activate	NULL
an	NULL
octamer	NULL
containing	NULL
promoter	NULL
element	NULL
in	NULL
fibroblasts	NULL
revealing	NULL
an	NULL
unexpected	NULL
functional	NULL
redundancy	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
show	NULL
that	NULL
one	NULL
of	NULL
the	NULL
isoforms	NULL
encodes	NULL
the	NULL
previously	NULL
described	NULL
lymphoid-specific	NULL
Oct2B	NULL
protein	NULL
which	NULL
has	NULL
been	NULL
suggested	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
function	NULL
of	NULL
the	NULL
octamer	NULL
motif	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
(	NULL
igh	NULL
)	NULL
enhancer	NULL
.	NULL

INTRODUCTION	NULL
The	NULL
lymphoid-specific	NULL
expression	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
is	NULL
regulated	NULL
by	NULL
at	NULL
least	NULL
two	NULL
distinct	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
,	NULL
the	NULL
upstream	NULL
promoter	NULL
and	NULL
the	NULL
intronic	NULL
enhancer	NULL
element	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

The	NULL
octamer	NULL
motif	NULL
ATGCAAAT	NULL
or	NULL
its	NULL
reverse	NULL
complement	NULL
ATTTGCAT	NULL
is	NULL
conserved	NULL
both	NULL
in	NULL
the	NULL
intronic	NULL
heavy-chain	NULL
enhancer	NULL
as	NULL
well	NULL
as	NULL
in	NULL
all	NULL
heavy	NULL
and	NULL
light-chain	NULL
gene	NULL
promoters	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

It	NULL
contributes	NULL
to	NULL
the	NULL
lymphoid-specific	NULL
activity	NULL
of	NULL
the	NULL
enhancer	NULL
(	NULL
7	NULL
)	NULL
and	NULL
plays	NULL
a	NULL
pivotal	NULL
role	NULL
for	NULL
immunoglobulin	NULL
promoter	NULL
activity	NULL
(	NULL
8	NULL
,	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
octamer	NULL
motif	NULL
is	NULL
not	NULL
exclusively	NULL
associated	NULL
with	NULL
regulatory	NULL
elements	NULL
involved	NULL
in	NULL
lymphoid-specific	NULL
expression	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
found	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
ubiquitously	NULL
expressed	NULL
genes	NULL
.	NULL

Cell	NULL
cycle	NULL
regulation	NULL
of	NULL
histone	NULL
H2B	NULL
gene	NULL
expression	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
governed	NULL
by	NULL
the	NULL
same	NULL
octamer	NULL
motif	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Transcription	NULL
of	NULL
genes	NULL
encoding	NULL
several	NULL
of	NULL
the	NULL
small	NULL
nuclear	NULL
RNAs	NULL
(	NULL
UsnRNAs	NULL
)	NULL
by	NULL
both	NULL
RNA	NULL
polymerase	NULL
II	NULL
and	NULL
III	NULL
is	NULL
also	NULL
dependent	NULL
on	NULL
a	NULL
functional	NULL
upstream	NULL
octamer	NULL
motif	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
octamer	NULL
element	NULL
has	NULL
also	NULL
been	NULL
implicated	NULL
in	NULL
adenovirus	NULL
replication	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Several	NULL
proteins	NULL
that	NULL
interact	NULL
with	NULL
the	NULL
conserved	NULL
octamer	NULL
motif	NULL
have	NULL
been	NULL
identified	NULL
and	NULL
characterized	NULL
to	NULL
different	NULL
extents	NULL
.	NULL

Octl	NULL
(	NULL
other	NULL
names	NULL
are	NULL
NF-A1	NULL
,	NULL
OTFIl	NULL
,	NULL
OBP	NULL
100	NULL
,	NULL
NFM	NULL
)	NULL
is	NULL
a	NULL
90-100kD	NULL
protein	NULL
which	NULL
seems	NULL
to	NULL
be	NULL
ubiquitously	NULL
expressed	NULL
(	NULL
15	NULL
,	NULL
16	NULL
,	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Two	NULL
lymphoid-specific	NULL
octamer	NULL
binding	NULL
proteins	NULL
have	NULL
been	NULL
described	NULL
:	NULL
Oct2A	NULL
(	NULL
other	NULL
designations	NULL
OTF2	NULL
,	NULL
NF-A2	NULL
)	NULL
,	NULL
a	NULL
protein	NULL
of	NULL
55	NULL
-60kD	NULL
(	NULL
19	NULL
,	NULL
20	NULL
,	NULL
21	NULL
)	NULL
and	NULL
Oct2B	NULL
(	NULL
OTF2B	NULL
)	NULL
a	NULL
75kD	NULL
protein	NULL
that	NULL
has	NULL
been	NULL
shown	NULL
by	NULL
a	NULL
proteolytic	NULL
clipping	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
to	NULL
be	NULL
related	NULL
to	NULL
Oct2A	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Octd	NULL
(	NULL
NF-A3	NULL
,	NULL
Oct3	NULL
)	NULL
has	NULL
been	NULL
detected	NULL
as	NULL
a	NULL
protein	NULL
specifically	NULL
expressed	NULL
in	NULL
undifferentiated	NULL
embryonal	NULL
stem	NULL
cells	NULL
and	NULL
embryonal	NULL
carcinoma	NULL
cell	NULL
lines	NULL
(	NULL
7	NULL
,	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
various	NULL
other	NULL
octamer	NULL
binding	NULL
proteins	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
extracts	NULL
from	NULL
different	NULL
cell	NULL
types	NULL
and	NULL
tissues	NULL
(	NULL
23	NULL
,	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
cDNA	NULL
clones	NULL
were	NULL
obtained	NULL
for	NULL
Oct1	NULL
,	NULL
Oct2A	NULL
and	NULL
Oct4	NULL
(	NULL
17	NULL
,	NULL
24	NULL
,	NULL
27	NULL
,	NULL
28	NULL
,	NULL
29	NULL
,	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
these	NULL
clones	NULL
revealed	NULL
that	NULL
they	NULL
are	NULL
members	NULL
of	NULL
a	NULL
novel	NULL
class	NULL
of	NULL
homeo-box	NULL
containing	NULL
transcription	NULL
factors	NULL
characterized	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
POU-domain	NULL
.	NULL

The	NULL
POU-domain	NULL
was	NULL
originally	NULL
described	NULL
as	NULL
a	NULL
region	NULL
of	NULL
homology	NULL
conserved	NULL
in	NULL
the	NULL
mammalian	NULL
transcription	NULL
factors	NULL
Pit-1	NULL
,	NULL
Oct-l1	NULL
and	NULL
Oct-2	NULL
as	NULL
well	NULL
as	NULL
the	NULL
Caenorhabditis	NULL
elegans	NULL
unc-86	NULL
gene	NULL
.	NULL

It	NULL
consists	NULL
of	NULL
a	NULL
POU-specific	NULL
(	NULL
75-80	NULL
amino	NULL
acids	NULL
long	NULL
)	NULL
and	NULL
a	NULL
POU-homeo	NULL
(	NULL
60	NULL
amino	NULL
acids	NULL
long	NULL
)	NULL
subdomain	NULL
separated	NULL
by	NULL
a	NULL
short	NULL
linker	NULL
(	NULL
17	NULL
,	NULL
32	NULL
)	NULL
.	NULL

cDNAs	NULL
encoding	NULL
additional	NULL
POU-domain	NULL
proteins	NULL
have	NULL
been	NULL
isolated	NULL
using	NULL
a	NULL
PCR	NULL
cloning	NULL
protocol	NULL
(	NULL
33	NULL
)	NULL
.	NULL

It	NULL
is	NULL
not	NULL
clear	NULL
,	NULL
however	NULL
,	NULL
whether	NULL
these	NULL
cDNAs	NULL
encode	NULL
some	NULL
of	NULL
the	NULL
octamer	NULL
binding	NULL
proteins	NULL
already	NULL
described	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Results	NULL
of	NULL
site	NULL
directed	NULL
mutagenesis	NULL
and	NULL
deletion	NULL
experiments	NULL
suggested	NULL
that	NULL
this	NULL
POU-domain	NULL
in	NULL
its	NULL
entirety	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
sequence-specific	NULL
DNA-binding	NULL
as	NULL
well	NULL
as	NULL
for	NULL
protein-protein	NULL
interactions	NULL
(	NULL
34	NULL
,	NULL
35	NULL
,	NULL
36	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
independently	NULL
isolated	NULL
human	NULL
Oct2A	NULL
cDNA	NULL
*	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
44	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

1	NULL
sequences	NULL
revealed	NULL
that	NULL
the	NULL
cDNAs	NULL
isolated	NULL
from	NULL
the	NULL
BJA-B	NULL
cell	NULL
line	NULL
encode	NULL
a	NULL
protein	NULL
that	NULL
contains	NULL
an	NULL
insert	NULL
of	NULL
16	NULL
amino	NULL
acids	NULL
that	NULL
is	NULL
absent	NULL
from	NULL
the	NULL
protein	NULL
encoded	NULL
by	NULL
the	NULL
cDNA	NULL
clone	NULL
isolated	NULL
from	NULL
Namalwa	NULL
cells	NULL
(	NULL
28	NULL
,	NULL
29	NULL
,	NULL
38	NULL
)	NULL
.	NULL

It	NULL
was	NULL
unclear	NULL
whether	NULL
the	NULL
two	NULL
forms	NULL
originated	NULL
by	NULL
transcription	NULL
of	NULL
highly	NULL
related	NULL
genes	NULL
or	NULL
whether	NULL
the	NULL
difference	NULL
was	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
alleles	NULL
or	NULL
an	NULL
alternative	NULL
splicing	NULL
mechanism	NULL
.	NULL

Here	NULL
we	NULL
report	NULL
the	NULL
isolation	NULL
and	NULL
characterization	NULL
of	NULL
multiple	NULL
functional	NULL
isoforms	NULL
of	NULL
Oct2	NULL
cDNA	NULL
from	NULL
murine	NULL
B-cells	NULL
.	NULL

We	NULL
show	NULL
that	NULL
they	NULL
are	NULL
generated	NULL
by	NULL
an	NULL
alternative	NULL
splicing	NULL
mechanism	NULL
.	NULL

Among	NULL
the	NULL
isolated	NULL
isoforms	NULL
are	NULL
both	NULL
homologues	NULL
of	NULL
the	NULL
two	NULL
described	NULL
human	NULL
cDNAs	NULL
and	NULL
a	NULL
clone	NULL
encoding	NULL
Oct2B	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Isolation	NULL
of	NULL
cDNA	NULL
clones	NULL
The	NULL
mouse	NULL
pre	NULL
B-cell	NULL
library	NULL
(	NULL
kind	NULL
gift	NULL
of	NULL
Dr.	NULL
P.	NULL
Nielson	NULL
,	NULL
MPI	NULL
Freiburg	NULL
)	NULL
in	NULL
Agt11	NULL
was	NULL
independently	NULL
screened	NULL
with	NULL
two	NULL
endlabelled	NULL
61	NULL
base	NULL
long	NULL
oligonucleotides	NULL
.	NULL

These	NULL
oligonucleotides	NULL
were	NULL
homologous	NULL
to	NULL
the	NULL
published	NULL
human	NULL
Oct2A	NULL
sequence	NULL
from	NULL
position	NULL
889	NULL
to	NULL
950	NULL
and	NULL
from	NULL
997	NULL
to	NULL
1058	NULL
,	NULL
respectively	NULL
(	NULL
28	NULL
)	NULL
.	NULL

For	NULL
PCR	NULL
amplification	NULL
the	NULL
following	NULL
two	NULL
primer	NULL
oligonucleotides	NULL
were	NULL
used	NULL
:	NULL
Oct	NULL
5	NULL
'	NULL
:	NULL
CTGGATCCGGGCAGCATGGTCGACTCC-AGCATGGGGGCTCCAG	NULL
Oct	NULL
3	NULL
'	NULL
:	NULL
AGGAATTCGAGGGGAGGCATGGCCGGCTCTC-ACTCAGCCTTGG	NULL
The	NULL
5	NULL
'	NULL
primer	NULL
contains	NULL
a	NULL
BamHI	NULL
cloning	NULL
site	NULL
upstream	NULL
and	NULL
a	NULL
Sall	NULL
site	NULL
downstream	NULL
of	NULL
the	NULL
AUG	NULL
start	NULL
codon	NULL
,	NULL
the	NULL
3	NULL
'	NULL
primer	NULL
contains	NULL
an	NULL
EcoRI	NULL
cloning	NULL
site	NULL
.	NULL

First	NULL
strand	NULL
cDNA	NULL
was	NULL
prepared	NULL
from	NULL
2ug	NULL
of	NULL
total	NULL
cytoplasmic	NULL
WEHI231	NULL
RNA	NULL
using	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
primers	NULL
and	NULL
MuLV	NULL
Reverse	NULL
Transcriptase	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
.	NULL

10	NULL
%	NULL
of	NULL
this	NULL
cDNA	NULL
was	NULL
directly	NULL
PCR	NULL
amplified	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
304	NULL
]	NULL
using	NULL
20pmol	NULL
of	NULL
the	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
primers	NULL
each	NULL
.	NULL

PCR	NULL
amplifications	NULL
were	NULL
done	NULL
with	NULL
1	NULL
unit	NULL
of	NULL
Tag-polymerase	NULL
(	NULL
Perkin	NULL
Elmer	NULL
)	NULL
for	NULL
40	NULL
seconds	NULL
at	NULL
4°C	NULL
,	NULL
1	NULL
min	NULL
at	NULL
65°C	NULL
,	NULL
2.5	NULL
min	NULL
at	NULL
72°C	NULL
(	NULL
3	NULL
cycles	NULL
)	NULL
followed	NULL
by	NULL
40	NULL
cycles	NULL
of	NULL
40	NULL
seconds	NULL
at	NULL
94°C	NULL
,	NULL
3	NULL
min	NULL
72°C	NULL
.	NULL

The	NULL
amplified	NULL
DNA	NULL
was	NULL
precipitated	NULL
,	NULL
digested	NULL
with	NULL
EcoRI	NULL
and	NULL
BamHI	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
BluescriptSK~	NULL
vector	NULL
.	NULL

90	NULL
clones	NULL
containing	NULL
Oct2	NULL
sequences	NULL
were	NULL
selected	NULL
for	NULL
further	NULL
analyses	NULL
.	NULL

DNA	NULL
was	NULL
digested	NULL
with	NULL
MspI	NULL
which	NULL
yields	NULL
about	NULL
15-20	NULL
fragments	NULL
that	NULL
could	NULL
be	NULL
resolved	NULL
on	NULL
40cm	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

This	NULL
analysis	NULL
allowed	NULL
classification	NULL
of	NULL
70	NULL
of	NULL
the	NULL
clones	NULL
into	NULL
the	NULL
classes	NULL
described	NULL
(	NULL
Oct2.1-Oct2.6	NULL
)	NULL
.	NULL

The	NULL
remaining	NULL
20	NULL
clones	NULL
were	NULL
single	NULL
isolates	NULL
and	NULL
have	NULL
not	NULL
been	NULL
characterized	NULL
further	NULL
.	NULL

Isolation	NULL
of	NULL
genomic	NULL
clones	NULL
Complete	NULL
Oct2	NULL
cDNA	NULL
inserts	NULL
were	NULL
used	NULL
for	NULL
screening	NULL
of	NULL
a	NULL
mouse	NULL
129	NULL
strain	NULL
cosmid	NULL
library	NULL
(	NULL
kind	NULL
gift	NULL
of	NULL
A.	NULL
Poustka	NULL
)	NULL
and	NULL
a	NULL
single	NULL
cosmid	NULL
was	NULL
repeatedly	NULL
isolated	NULL
.	NULL

As	NULL
this	NULL
cosmid	NULL
was	NULL
lacking	NULL
the	NULL
first	NULL
3	NULL
coding	NULL
exons	NULL
,	NULL
we	NULL
constructed	NULL
a	NULL
AEMBL3	NULL
genomic	NULL
library	NULL
from	NULL
C57Bl/6	NULL
mouse	NULL
spleen	NULL
DNA	NULL
.	NULL

2x	NULL
10°	NULL
phages	NULL
from	NULL
the	NULL
unamplified	NULL
library	NULL
were	NULL
screened	NULL
using	NULL
a	NULL
probe	NULL
containing	NULL
the	NULL
first	NULL
180bp	NULL
of	NULL
the	NULL
Oct2	NULL
cDNA	NULL
and	NULL
two	NULL
phages	NULL
containing	NULL
non-overlapping	NULL
inserts	NULL
were	NULL
isolated	NULL
.	NULL

One	NULL
of	NULL
them	NULL
was	NULL
contiguous	NULL
with	NULL
the	NULL
previously	NULL
isolated	NULL
cosmid	NULL
clone	NULL
and	NULL
contained	NULL
exons	NULL
2	NULL
and	NULL
3	NULL
.	NULL

The	NULL
other	NULL
started	NULL
about	NULL
2	NULL
kb	NULL
upstream	NULL
of	NULL
the	NULL
first	NULL
phage	NULL
insert	NULL
(	NULL
determined	NULL
by	NULL
genomic	NULL
Southern	NULL
blots	NULL
with	NULL
several	NULL
enzymes	NULL
)	NULL
and	NULL
contained	NULL
exon	NULL
1	NULL
.	NULL

Subcloning	NULL
and	NULL
sequencing	NULL
Fragments	NULL
from	NULL
the	NULL
genomic	NULL
clones	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
pBluescriptSK~	NULL
vector	NULL
.	NULL

For	NULL
sequence	NULL
analysis	NULL
multiple	NULL
additional	NULL
subclones	NULL
were	NULL
generated	NULL
for	NULL
dideoxy	NULL
sequencing	NULL
with	NULL
M13	NULL
universal/reverse	NULL
primers	NULL
.	NULL

In	NULL
addition	NULL
several	NULL
oligonucleotides	NULL
were	NULL
generated	NULL
from	NULL
the	NULL
Oct2	NULL
cDNA	NULL
sequence	NULL
and	NULL
used	NULL
for	NULL
sequencing	NULL
.	NULL

Sequencing	NULL
was	NULL
done	NULL
on	NULL
double	NULL
stranded	NULL
DNA	NULL
using	NULL
dITP	NULL
as	NULL
well	NULL
as	NULL
standard	NULL
nucleotides	NULL
and	NULL
T7	NULL
DNA	NULL
Polymerase	NULL
(	NULL
Pharmacia	NULL
)	NULL
according	NULL
to	NULL
manufacturers	NULL
specifications	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
cDNA	NULL
containing	NULL
plasmids	NULL
(	NULL
14g	NULL
)	NULL
were	NULL
linearized	NULL
with	NULL
EcoRI	NULL
and	NULL
RNA	NULL
was	NULL
synthesized	NULL
using	NULL
T3	NULL
RNA	NULL
polymerase	NULL
according	NULL
to	NULL
manufacturers	NULL
instructions	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

/n	NULL
vitro	NULL
translation	NULL
with	NULL
lug	NULL
of	NULL
RNA	NULL
was	NULL
performed	NULL
in	NULL
rabbit	NULL
reticulocyte	NULL
lysates	NULL
(	NULL
Promega	NULL
)	NULL
following	NULL
manufacturers	NULL
specifications	NULL
.	NULL

104Ci	NULL
S-labelled	NULL
methionine	NULL
was	NULL
included	NULL
in	NULL
the	NULL
reactions	NULL
.	NULL

1/25	NULL
of	NULL
the	NULL
in	NULL
vitro	NULL
translation	NULL
was	NULL
analyzed	NULL
on	NULL
a	NULL
10	NULL
%	NULL
SDS	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

As	NULL
probes	NULL
for	NULL
the	NULL
EMSA	NULL
,	NULL
wild-type	NULL
or	NULL
mutant	NULL
octamer	NULL
oligonucleotides	NULL
cloned	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
pUC18	NULL
and	NULL
subsequently	NULL
excised	NULL
with	NULL
EcoRI/HindIII	NULL
were	NULL
used	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Binding	NULL
reactions	NULL
contained	NULL
50	NULL
mM	NULL
NaCL	NULL
,	NULL
10	NULL
mM	NULL
Tris/HCl	NULL
pH	NULL
7.5	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
34g	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
5000	NULL
cpm	NULL
of	NULL
the	NULL
respective	NULL
probe	NULL
and	NULL
1/25	NULL
of	NULL
the	NULL
in	NULL
vitro	NULL
translation	NULL
reaction	NULL
.	NULL

Native	NULL
gels	NULL
were	NULL
run	NULL
in	NULL
0.5	NULL
XTBE	NULL
buffer	NULL
,	NULL
dried	NULL
and	NULL
exposed	NULL
for	NULL
12hrs	NULL
with	NULL
two	NULL
layers	NULL
of	NULL
paper	NULL
interleaved	NULL
to	NULL
suppress	NULL
signals	NULL
originating	NULL
from	NULL
the	NULL
labelled	NULL
proteins	NULL
.	NULL

Cell	NULL
and	NULL
tissue	NULL
culture	NULL
and	NULL
transfections	NULL
Lymphoid	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
Iscove	NULL
's	NULL
modified	NULL
DMEM	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
10aM	NULL
B-mercaptoethanol	NULL
and	NULL
antibiotics	NULL
.	NULL

NIH/3T3	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
DMEM	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
calf	NULL
serum	NULL
,	NULL
5	NULL
%	NULL
newborn	NULL
calf	NULL
serum	NULL
and	NULL
antibiotics	NULL
.	NULL

For	NULL
mitogen	NULL
stimulations	NULL
spleen	NULL
single	NULL
cells	NULL
(	NULL
about	NULL
5x10°	NULL
cells/ml	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
30ug/ml	NULL
lipopolysaccharide	NULL
(	NULL
Sigma	NULL
)	NULL
or	NULL
with	NULL
3ug/ml	NULL
concanavalinA	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
48	NULL
hrs	NULL
.	NULL

Transfections	NULL
were	NULL
done	NULL
by	NULL
the	NULL
calcium-phosphate	NULL
co-precipitation	NULL
method	NULL
.	NULL

2	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5ug	NULL
of	NULL
the	NULL
reporter	NULL
plasmids	NULL
plus	NULL
Zug	NULL
of	NULL
the	NULL
Oct2	NULL
cDNA	NULL
expression	NULL
constructs	NULL
.	NULL

Sheared	NULL
salmon	NULL
sperm	NULL
DNA	NULL
was	NULL
added	NULL
to	NULL
adjust	NULL
the	NULL
amount	NULL
of	NULL
transfected	NULL
DNA	NULL
to	NULL
201g	NULL
.	NULL

4	NULL
hrs	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
DNA	NULL
precipitate	NULL
a	NULL
DMSO	NULL
shock	NULL
was	NULL
performed	NULL
.	NULL

Cytoplasmic	NULL
RNA	NULL
was	NULL
prepared	NULL
44	NULL
hrs	NULL
later	NULL
as	NULL
described	NULL
(	NULL
39	NULL
)	NULL
.	NULL

RNA	NULL
analysis	NULL
$	NULL
1	NULL
analysis	NULL
with	NULL
the	NULL
mouse	NULL
histone	NULL
H4	NULL
probe	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

For	NULL
primer	NULL
extension	NULL
analysis	NULL
3Omg	NULL
of	NULL
cytoplasmic	NULL
RNA	NULL
was	NULL
coprecipitated	NULL
with	NULL
0.01pmol	NULL
!	NULL

(	NULL
typically	NULL
about	NULL
25,000	NULL
cpm	NULL
)	NULL
of	NULL
5	NULL
'	NULL
end	NULL
labelled	NULL
primer	NULL
CTG3	NULL
'	NULL
)	NULL
.	NULL

Hybridization	NULL
was	NULL
performed	NULL
in	NULL
104l	NULL
of	NULL
250mM	NULL
KCI	NULL
,	NULL
10	NULL
mM	NULL
Tris/HCl	NULL
pH7.5	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
for	NULL
1	NULL
hr	NULL
at	NULL
60°C	NULL
,	NULL
then	NULL
40ul	NULL
of	NULL
1	NULL
%	NULL
Reverse	NULL
Transcriptase	NULL
buffer	NULL
containing	NULL
0.5	NULL
mM	NULL
of	NULL
each	NULL
dNTP	NULL
,	NULL
0.1	NULL
mg	NULL
BSA	NULL
and	NULL
200	NULL
U	NULL
MuLV	NULL
Reverse	NULL
Transcriptase	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
was	NULL
added	NULL
.	NULL

Reactions	NULL
were	NULL
terminated	NULL
after	NULL
1	NULL
hr	NULL
at	NULL
37°C	NULL
,	NULL
precipitated	NULL
and	NULL
analyzed	NULL
on	NULL
10	NULL
%	NULL
denaturing	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

RNase	NULL
protection	NULL
analysis	NULL
was	NULL
essentially	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
40	NULL
)	NULL
.	NULL

RNA	NULL
from	NULL
primary	NULL
cells	NULL
and	NULL
organs	NULL
was	NULL
isolated	NULL
by	NULL
the	NULL
guanidinium-isothiocyanate/CsCl	NULL
centrifugation	NULL
method	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
RNA	NULL
from	NULL
cell	NULL
lines	NULL
was	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Typically	NULL
10	NULL
to	NULL
304g	NULL
RNA	NULL
was	NULL
hybridized	NULL
to	NULL
500,000	NULL
cpm	NULL
of	NULL
RNA	NULL
probe	NULL
synthesized	NULL
by	NULL
transcription	NULL
with	NULL
either	NULL
T3	NULL
or	NULL
T7	NULL
RNA	NULL
polymerase	NULL
.	NULL

Protected	NULL
fragments	NULL
were	NULL
analyzed	NULL
on	NULL
6	NULL
%	NULL
denaturing	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

Western	NULL
analysis	NULL
150ug	NULL
of	NULL
nuclear	NULL
proteins	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
41	NULL
)	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
10	NULL
%	NULL
SDS	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
40	NULL
)	NULL
and	NULL
then	NULL
electrophoretically	NULL
transferred	NULL
for	NULL
2	NULL
hrs	NULL
at	NULL
SOV	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
using	NULL
a	NULL
BioRad	NULL
transblot	NULL
cell	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
stained	NULL
with	NULL
Ponceaus	NULL
$	NULL
to	NULL
visualize	NULL
the	NULL
molecular	NULL
weight	NULL
standards	NULL
and	NULL
was	NULL
blocked	NULL
using	NULL
2	NULL
%	NULL
dry	NULL
milk	NULL
after	NULL
destaining	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
reacted	NULL
with	NULL
mouse	NULL
antisera	NULL
raised	NULL
against	NULL
bacterially	NULL
B	NULL
won	NULL
won	NULL
won	NULL
a	NULL
wie	NULL
wove	NULL
I	NULL
crecacamat	NULL
2.1	NULL
2.2	NULL
A	NULL
1	NULL
ccoccaecar	NULL
corTcatice	NULL
accaTosose	NULL
ARGAATGTCT	NULL
MAGCCCCTGG	NULL
2.3	NULL
pals	NULL
-	NULL
i	NULL
2.4	NULL
el	NULL
AcoccGaGrA	NULL
GACTCCCCGT	NULL
CAGAGCACAC	NULL
AGACACCGMA	NULL
AGMAATGCAC	NULL
2.5	NULL
2.6	NULL
121°	NULL
CoomeRTTAA	NULL
CCATCAGAAC	NULL
CCCCAGRATA	NULL
AMGCGTCCCC	NULL
MTICTCTGTG	NULL
ZCCCCAACTS	NULL
I	NULL
181	NULL
aceceaacac	NULL
eaacoTcoot	NULL
ATTCTCTCTG	NULL
GCCTCCACTT	NULL
MACATTCTGG	NULL
GeTCccooac	NULL
2.1	NULL
241	NULL
CCTeCCTCTC	NULL
TCCTECCCAG	NULL
ATCAMGGCTG	NULL
AMGACCCCAG	NULL
TGGCGATICA	NULL
2.2	NULL
2.3	NULL
301	NULL
cacceetece	NULL
ccecersees	NULL
Amereceeca	NULL
AToccacoc	NULL
2.4	NULL
t	NULL
361	NULL
acasceroer	NULL
Accresouac	NULL
aTacrecame	NULL
ccaocaoe	NULL
?	NULL

o	NULL
GGC	NULL
2.5	NULL
2.6	NULL
421.	NULL
ceccccacc®	NULL
cerecaccca	NULL
ccrectcat	NULL
Tcerecrece	NULL
Acaccaca	NULL
CAGA	NULL
oc	NULL
1	NULL
481.	NULL
cacscctect	NULL
accamcooca	NULL
AMTCTATICC	NULL
AGCTACCTCA	NULL
ACAAACCCAG	NULL
GGMGCICTCC	NULL
2.1	NULL
1	NULL
sal	NULL
.	NULL

TGAcCTcoom	NULL
GCCceGGeet	NULL
GGGCTReeT®	NULL
CACAGGCTAT	NULL
GaCTCCcC¢	NULL
AcoeToceco	NULL
i	NULL
'	NULL
;	NULL
i	NULL
é1	NULL
.	NULL

acceacacer	NULL
ereacacete	NULL
caceecesa	NULL
ccceccerce	NULL
2.4	NULL
2.5	NULL
gel	NULL
|	NULL
AGCCCaGeo®	NULL
ToGcaGcAG	NULL
CTGGMACAGT	NULL
TTGCTCGCAC	NULL
CTICAAGCAA	NULL
CGCCoCA	NULL
:	NULL
~A	NULL
2.6	NULL
I	NULL
121	NULL
|	NULL
Accreceett	NULL
cacacaseet	NULL
caerGece	NULL
reeccatees	NULL
CaMGCTcTaT	NULL
re	NULL
:	NULL
|	NULL
TcAGCCMMAC	NULL
GACCATITCC	NULL
CGCTTCGAGG	NULL
CCCTCAACCT	NULL
GAGCTICAAG	NULL
AMCATGTOTA	NULL
2.1	NULL
|	NULL
2.2	NULL
g41	NULL
|	NULL
AACTCRAGCC	NULL
CCTCCTGGAG	NULL
AMGTGGCTCA	NULL
ACGACGCAGA	NULL
GTocATTCAA	NULL
2.3	NULL
2.4	NULL
801.	NULL
aeeracceas	NULL
cccamaccas	NULL
ctemecasce	NULL
ccascetses	NULL
Trreeacése	NULL
creccodout	NULL
2.5	NULL
961	NULL
jGACGCAA	NULL
GRAGAGGACC	NULL
AGCATCGAGA	NULL
CGAMTGTCCG	NULL
CTICGCCTTA	NULL
GAGAMGAGTT	NULL
2.6	NULL
I	NULL
1021	NULL
|	NULL
CcAGAAGCCT	NULL
ACCTEAGAGG	NULL
AGATCCIGCT	NULL
GATCGCAGAG	NULL
CRGCIGCACA	NULL
2.1	NULL
108	NULL
;	NULL
|	NULL
TocAGaMGc®	NULL
AGTGATCCGC	NULL
GTCTGGTICT	NULL
GCAACCGSCG	NULL
CCAGAAGGAG	NULL
MMACGCATCA	NULL
2.2	NULL
141	NULL
|	NULL
adcerracas	NULL
ATGCTGCCCA	NULL
GCCGACCAGC	NULL
TACRGCCCIC	NULL
2.3	NULL
i	NULL
1201	NULL
accreetcac	NULL
GecécroGc®	NULL
CCTTAcCATT	NULL
Teraccaotc	NULL
2.5	NULL
1	NULL
2.6	NULL
1261	NULL
TeaGcaCAA	NULL
AGTTACTACC	NULL
TTATCCTCAG	NULL
CTGTGGGGAC	NULL
GCTCCATCCC	NULL
132100	NULL
teesecteee	NULL
cecccacote	NULL
ereeeeer	NULL
CaRTICCATC	NULL
CoctCrorca	NULL
2.	NULL
i	NULL
asi	NULL
erececerce	NULL
Accaacacca	NULL
caraccesas	NULL
acccactcos	NULL
2.2	NULL
2.3	NULL
«	NULL
41	NULL
.	NULL

ctatTesert	NULL
Amccccacce	NULL
CoecaaGcac	NULL
TTGAGCTCTG	NULL
2.4	NULL
I	NULL
2.5	NULL
secreretce	NULL
Accaachace	NULL
cTrosccac	NULL
TaTccamoce	NULL
cteccctcto	NULL
2.6	NULL
se	NULL
:	NULL
ereemaecer	NULL
ceceetmAce	NULL
Accetieate	NULL
ccasceccam	NULL
cereetecre	NULL
cooocaecce	NULL
re	NULL
?	NULL

atecesecee	NULL
AcseaTcee	NULL
McTTaotMm	NULL
corcecerer	NULL
CrTeTtorac	NULL
cacaccostc	NULL
2.1	NULL
2.2	NULL
lési	NULL
Tecescrecr	NULL
castocecca	NULL
coaccostee	NULL
GCcreetcrc	NULL
Meceeceact	NULL
GCaGccotAc	NULL
2.3	NULL
1741	NULL
``	NULL
ereeatcear	NULL
Tetccrece	NULL
Terccrcere	NULL
TCATCATCCT	NULL
2.2	NULL
ecacotecas	NULL
reatercac®	NULL
acacacaeee	NULL
ctocacscec	NULL
cosmecacee	NULL
commecctea	NULL
croacaGccs	NULL
GecaTeeere	NULL
©	NULL
2.5	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

1	NULL
45	NULL
produced	NULL
Oct2	NULL
isoforms	NULL
(	NULL
42	NULL
)	NULL
and	NULL
subsequently	NULL
with	NULL
an	NULL
alkaline	NULL
phosphatase	NULL
coupled	NULL
goat	NULL
anti-mouse	NULL
antibody	NULL
(	NULL
Jackson	NULL
laboratories	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
developed	NULL
as	NULL
described	NULL
(	NULL
42	NULL
)	NULL
.	NULL

RESULTS	NULL
Multiple	NULL
Oct2	NULL
related	NULL
RNA	NULL
species	NULL
are	NULL
present	NULL
in	NULL
B-cells	NULL
Initially	NULL
we	NULL
had	NULL
isolated	NULL
a	NULL
partial	NULL
Oct2	NULL
cDNA	NULL
clone	NULL
by	NULL
standard	NULL
techniques	NULL
from	NULL
a	NULL
murine	NULL
pre	NULL
B-cell	NULL
library	NULL
using	NULL
oligonucleotides	NULL
homologous	NULL
to	NULL
the	NULL
POU-specific	NULL
region	NULL
and	NULL
the	NULL
POU-homeodomain	NULL
of	NULL
the	NULL
published	NULL
human	NULL
Oct2A	NULL
cDNA	NULL
sequence	NULL
as	NULL
probes	NULL
(	NULL
38	NULL
)	NULL
.	NULL

This	NULL
clone	NULL
did	NULL
not	NULL
extend	NULL
to	NULL
the	NULL
amino	NULL
terminus	NULL
of	NULL
the	NULL
coding	NULL
region	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
subsequently	NULL
used	NULL
oligonucleotide	NULL
primers	NULL
from	NULL
within	NULL
this	NULL
partial	NULL
cDNA	NULL
clone	NULL
and	NULL
primers	NULL
that	NULL
were	NULL
either	NULL
homologous	NULL
to	NULL
the	NULL
amino	NULL
terminal	NULL
1	NULL
70	NULL
MVHSSMGAPE	NULL
IRMSKPLEAE	NULL
KOSLDSPSEH	NULL
TDTERNGPDI	NULL
NHONPQNKAS	NULL
PFsVSPTGPS	NULL
TK	NULL
--	NULL
VGILSGLH	NULL
71	NULL
140	NULL
IKAEDP	NULL
SGDSAPAAPP	NULL
PPOPAGPHLP	NULL
QAQLMLTGSQ	NULL
LAGDIQQLLQ	NULL
LOQLVLVPGK	NULL
LTEMGPGPCL	NULL
sPpQ	NULL
:	NULL
141	NULL
210	NULL
HLOPPAQFLL	NULL
PQAQOSQPGL	NULL
LPTPNLFQLP	NULL
QQTQGALLTS	NULL
QPRAGLPT	NULL
QPPKCL	NULL
QA	NULL
MTRPTLPDPH	NULL
LSHP	NULL
--	NULL
~	NULL
--	NULL
-211	NULL
280	NULL
POU	NULL
-	NULL
specific	NULL
domain	NULL
DLEELEQOFAR	NULL
TFKORRIKLG	NULL
FTQGDVGLAM	NULL
GKLYGNDFSQ	NULL
TTISRFEALN	NULL
LSFKNMCKLK	NULL
281	NULL
POU	NULL
-	NULL
homeo	NULL
domain	NULL
350	NULL
PLLEKWLNDA	NULL
HTMSVDSSLP	NULL
SPNOLSSPSL	NULL
GFDGLPGRRR	NULL
KKRTSIETNV	NULL
RFALEKSFLA	NULL
NQKPTSEEIL	NULL
351	NULL
P	NULL
»	NULL
420	NULL
LIAEOLHMEK	NULL
EVIRVWFCNR	NULL
RQKEKRINPC	NULL
SAAPMLPSPG	NULL
KPTSYSPHLV	NULL
TPQGGAGTLE	NULL
LSQASSSLST	NULL
421	NULL
.	NULL

e	NULL
490	NULL
TVTTLSSAVG	NULL
TLHPSRTAGG	NULL
GGGGGGRALP	NULL
LNSIPSVTPP	NULL
PPATTNSTNP	NULL
SPQGSHSAIG	NULL
LSGLNPSAGP	NULL
s	NULL
a91	NULL
560	NULL
GLWWNPAPYQ	NULL
P*	NULL
__________	NULL
-+	NULL
__________	NULL
-+	NULL
TMVGLSSGLS	NULL
-ALMSNNPLA	NULL
TIQALASGGT	NULL
LPLTSLDGSG	NULL
NLVLGAAGAA	NULL
PGSPSLVTSP	NULL
LFLNHTGLPL	NULL
__________	NULL
-+	NULL
561	NULL
621	NULL
LSAPPGVGLV	NULL
SAAMAMAVAAS	NULL
ISSKSPGLSS	NULL
SSSSSSSSTC	NULL
SDVAAQTPGG	NULL
PGGPEAGSKA	NULL
E	NULL
#	NULL
Figure	NULL
1	NULL
:	NULL
Nucleotide	NULL
and	NULL
protein	NULL
sequences	NULL
of	NULL
the	NULL
various	NULL
Oct2	NULL
isoforms	NULL
.	NULL

A	NULL
.	NULL
)	NULL

The	NULL
composite	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
mouse	NULL
cDNAs	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
sequence	NULL
starts	NULL
8	NULL
or	NULL
23bp	NULL
upstream	NULL
of	NULL
the	NULL
AUG	NULL
startcodon	NULL
,	NULL
depending	NULL
on	NULL
which	NULL
one	NULL
of	NULL
the	NULL
two	NULL
in	NULL
frame	NULL
AUG	NULL
codons	NULL
is	NULL
used	NULL
(	NULL
AUG	NULL
codons	NULL
underlined	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
first	NULL
40bp	NULL
is	NULL
actually	NULL
taken	NULL
from	NULL
the	NULL
genomic	NULL
clones	NULL
because	NULL
the	NULL
oligonucleotide	NULL
used	NULL
for	NULL
PCR	NULL
amplification	NULL
contained	NULL
several	NULL
point	NULL
mutations	NULL
in	NULL
order	NULL
to	NULL
introduce	NULL
convenient	NULL
cloning	NULL
sites	NULL
.	NULL

The	NULL
regions	NULL
encoding	NULL
the	NULL
POU-specific	NULL
domain	NULL
and	NULL
the	NULL
POU-homeo	NULL
domain	NULL
are	NULL
boxed	NULL
,	NULL
positions	NULL
of	NULL
splice	NULL
sites	NULL
used	NULL
to	NULL
generate	NULL
the	NULL
various	NULL
isoforms	NULL
are	NULL
indicated	NULL
by	NULL
vertical	NULL
lines	NULL
.	NULL

B	NULL
.	NULL
)	NULL

Predicted	NULL
amino-acid	NULL
sequences	NULL
of	NULL
the	NULL
six	NULL
Oct2	NULL
proteins	NULL
.	NULL

The	NULL
full	NULL
sequence	NULL
of	NULL
the	NULL
major	NULL
Oct2	NULL
form	NULL
(	NULL
Oct2.1	NULL
)	NULL
is	NULL
shown	NULL
,	NULL
for	NULL
the	NULL
other	NULL
isoforms	NULL
only	NULL
the	NULL
divergent	NULL
sequences	NULL
are	NULL
shown	NULL
.	NULL

Identical	NULL
amino-acids	NULL
are	NULL
indicated	NULL
by	NULL
dashes	NULL
(	NULL
-	NULL
)	NULL
,	NULL
stop	NULL
codons	NULL
are	NULL
indicated	NULL
by	NULL
asterisks	NULL
.	NULL

The	NULL
POU-specific	NULL
and	NULL
the	NULL
POU-homeo	NULL
domain	NULL
are	NULL
boxed	NULL
again	NULL
,	NULL
the	NULL
4	NULL
leucine	NULL
residues	NULL
that	NULL
constitute	NULL
the	NULL
presumptive	NULL
leucine	NULL
zipper	NULL
are	NULL
hallmarked	NULL
by	NULL
dots	NULL
.	NULL

46	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

1	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
cDNA	NULL
or	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
cloned	NULL
murine	NULL
cDNA	NULL
to	NULL
amplify	NULL
Oct2	NULL
cDNA	NULL
sequences	NULL
by	NULL
PCR	NULL
.	NULL

Surprisingly	NULL
,	NULL
we	NULL
obtained	NULL
alternate	NULL
forms	NULL
of	NULL
both	NULL
the	NULL
5	NULL
'	NULL
as	NULL
well	NULL
as	NULL
the	NULL
3	NULL
'	NULL
end	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
which	NULL
5	NULL
'	NULL
ends	NULL
would	NULL
be	NULL
associated	NULL
with	NULL
which	NULL
3	NULL
'	NULL
ends	NULL
,	NULL
we	NULL
used	NULL
the	NULL
PCR	NULL
technique	NULL
to	NULL
amplify	NULL
the	NULL
complete	NULL
murine	NULL
homologue	NULL
of	NULL
the	NULL
published	NULL
human	NULL
cDNA	NULL
(	NULL
for	NULL
experimental	NULL
details	NULL
,	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
section	NULL
)	NULL
.	NULL

The	NULL
amplified	NULL
DNA	NULL
was	NULL
subcloned	NULL
into	NULL
a	NULL
plasmid	NULL
vector	NULL
and	NULL
90	NULL
independent	NULL
clones	NULL
containing	NULL
Oct2	NULL
sequences	NULL
were	NULL
selected	NULL
for	NULL
further	NULL
analyses	NULL
.	NULL

Using	NULL
frequently	NULL
cutting	NULL
restriction	NULL
enzymes	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
classify	NULL
about	NULL
80	NULL
%	NULL
of	NULL
these	NULL
cDNAs	NULL
into	NULL
6	NULL
different	NULL
forms	NULL
.	NULL

At	NULL
least	NULL
two	NULL
isolates	NULL
for	NULL
each	NULL
form	NULL
were	NULL
obtained	NULL
.	NULL

The	NULL
remaining	NULL
20	NULL
%	NULL
of	NULL
the	NULL
cDNA	NULL
clones	NULL
were	NULL
single	NULL
isolates	NULL
and	NULL
not	NULL
characterized	NULL
further	NULL
.	NULL

More	NULL
than	NULL
half	NULL
(	NULL
63	NULL
%	NULL
)	NULL
of	NULL
the	NULL
repeatedly	NULL
isolated	NULL
clones	NULL
belonged	NULL
to	NULL
the	NULL
class	NULL
designated	NULL
Oct2.1	NULL
.	NULL

The	NULL
other	NULL
forms	NULL
were	NULL
present	NULL
at	NULL
lower	NULL
frequencies	NULL
comprising	NULL
between	NULL
3	NULL
%	NULL
(	NULL
Oct2.6	NULL
)	NULL
and	NULL
12	NULL
%	NULL
(	NULL
Oct2.3	NULL
)	NULL
of	NULL
the	NULL
clones	NULL
.	NULL

Figure	NULL
1	NULL
shows	NULL
the	NULL
composite	NULL
nucleotide	NULL
sequences	NULL
and	NULL
a	NULL
summary	NULL
of	NULL
the	NULL
deduced	NULL
amino	NULL
acid	NULL
sequences	NULL
of	NULL
the	NULL
6	NULL
forms	NULL
(	NULL
Oct2.1-Oct2.6	NULL
)	NULL
characterized	NULL
in	NULL
this	NULL
report	NULL
.	NULL

The	NULL
dominant	NULL
form	NULL
(	NULL
Oct2.1	NULL
)	NULL
is	NULL
98.5	NULL
%	NULL
identical	NULL
to	NULL
the	NULL
human	NULL
Oct2	NULL
clone	NULL
isolated	NULL
from	NULL
Namalwa	NULL
cells	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Oct2.2	NULL
shares	NULL
the	NULL
same	NULL
degree	NULL
of	NULL
identity	NULL
with	NULL
the	NULL
Oct2	NULL
clones	NULL
isolated	NULL
from	NULL
the	NULL
human	NULL
BJA	NULL
-B	NULL
cell	NULL
line	NULL
(	NULL
28	NULL
,	NULL
38	NULL
)	NULL
.	NULL

The	NULL
difference	NULL
between	NULL
the	NULL
two	NULL
clones	NULL
is	NULL
due	NULL
to	NULL
an	NULL
in	NULL
frame	NULL
insert	NULL
of	NULL
48bp	NULL
(	NULL
16	NULL
aa	NULL
)	NULL
that	NULL
are	NULL
present	NULL
in	NULL
form	NULL
Oct2.2	NULL
but	NULL
not	NULL
in	NULL
Oct2.1	NULL
(	NULL
nor	NULL
in	NULL
any	NULL
of	NULL
the	NULL
other	NULL
Oct2	NULL
variants	NULL
)	NULL
.	NULL

The	NULL
other	NULL
Oct2	NULL
variants	NULL
have	NULL
not	NULL
yet	NULL
been	NULL
described	NULL
.	NULL

Oct2.3	NULL
has	NULL
an	NULL
in	NULL
frame	NULL
insert	NULL
of	NULL
66bp	NULL
(	NULL
22aa	NULL
)	NULL
close	NULL
to	NULL
the	NULL
amino	NULL
terminus	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

Oct2.6	NULL
shows	NULL
an	NULL
in	NULL
frame	NULL
deletion	NULL
of	NULL
117bp	NULL
(	NULL
39aa	NULL
)	NULL
starting	NULL
at	NULL
the	NULL
insertion	NULL
site	NULL
of	NULL
the	NULL
extra	NULL
66bp	NULL
of	NULL
variant	NULL
Oct2.3	NULL
and	NULL
extending	NULL
towards	NULL
the	NULL
carboxy	NULL
terminus	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

The	NULL
alterations	NULL
in	NULL
Oct2.4	NULL
and	NULL
Oct2.5	NULL
are	NULL
both	NULL
localized	NULL
3	NULL
'	NULL
of	NULL
the	NULL
conserved	NULL
POU-domain	NULL
and	NULL
change	NULL
the	NULL
reading	NULL
frame	NULL
.	NULL

Oct2.4	NULL
lacks	NULL
136bp	NULL
and	NULL
runs	NULL
into	NULL
a	NULL
stop	NULL
codon	NULL
17aa	NULL
downstream	NULL
of	NULL
the	NULL
deletion	NULL
site	NULL
.	NULL

This	NULL
modification	NULL
destroys	NULL
the	NULL
putative	NULL
leucine	NULL
zipper	NULL
(	NULL
28	NULL
,	NULL
29	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Oct2.5	NULL
contains	NULL
a	NULL
74bp	NULL
insert	NULL
12aa	NULL
upstream	NULL
of	NULL
the	NULL
termination	NULL
codon	NULL
of	NULL
variants	NULL
Oct2.1	NULL
,	NULL
Oct2.2	NULL
,	NULL
Oct2.3	NULL
and	NULL
Oct2.6	NULL
.	NULL

Due	NULL
to	NULL
this	NULL
insertion	NULL
and	NULL
the	NULL
resulting	NULL
frame	NULL
shift	NULL
,	NULL
this	NULL
variant	NULL
encodes	NULL
132	NULL
new	NULL
amino	NULL
acids	NULL
at	NULL
the	NULL
carboxy	NULL
terminus	NULL
.	NULL

The	NULL
predicted	NULL
molecular	NULL
weights	NULL
of	NULL
the	NULL
proteins	NULL
encoded	NULL
by	NULL
the	NULL
variant	NULL
forms	NULL
indicate	NULL
that	NULL
Oct2.1	NULL
,	NULL
Oct2.2	NULL
and	NULL
Oct2.3	NULL
with	NULL
molecular	NULL
weights	NULL
of	NULL
approximately	NULL
57	NULL
,	NULL
59	NULL
and	NULL
6OkD	NULL
could	NULL
be	NULL
considered	NULL
Oct2A	NULL
type	NULL
proteins	NULL
(	NULL
21	NULL
)	NULL
.	NULL

With	NULL
a	NULL
predicted	NULL
molecular	NULL
weight	NULL
of	NULL
75kD	NULL
,	NULL
Oct2.5	NULL
is	NULL
a	NULL
prime	NULL
candidate	NULL
to	NULL
encode	NULL
the	NULL
previously	NULL
described	NULL
Oct2B	NULL
protein	NULL
(	NULL
22	NULL
)	NULL
.	NULL

No	NULL
lymphoid	NULL
specific	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
molecular	NULL
weights	NULL
corresponding	NULL
to	NULL
the	NULL
smaller	NULL
Oct2.4	NULL
and	NULL
Oct2.6	NULL
forms	NULL
(	NULL
49	NULL
and	NULL
S2kD	NULL
,	NULL
respectively	NULL
)	NULL
have	NULL
been	NULL
described	NULL
.	NULL

Variant	NULL
Oct2	NULL
isoforms	NULL
are	NULL
generated	NULL
by	NULL
alternative	NULL
splicing	NULL
In	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
these	NULL
variant	NULL
forms	NULL
were	NULL
encoded	NULL
by	NULL
different	NULL
genes	NULL
or	NULL
generated	NULL
by	NULL
a	NULL
post-transcriptional	NULL
mechanism	NULL
,	NULL
we	NULL
isolated	NULL
genomic	NULL
cosmid	NULL
and	NULL
phage	NULL
clones	NULL
covering	NULL
the	NULL
region	NULL
represented	NULL
in	NULL
the	NULL
cDNAs	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
genomic	NULL
DNA	NULL
established	NULL
that	NULL
the	NULL
Oct2	NULL
protein	NULL
encoding	NULL
portion	NULL
of	NULL
the	NULL
cDNAs	NULL
is	NULL
spread	NULL
over	NULL
more	NULL
than	NULL
35kb	NULL
of	NULL
a	NULL
single	NULL
gene	NULL
locus	NULL
and	NULL
is	NULL
split	NULL
into	NULL
a	NULL
total	NULL
of	NULL
14	NULL
exons	NULL
(	NULL
Figure	NULL
2A	NULL
)	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
due	NULL
to	NULL
the	NULL
way	NULL
the	NULL
cDNA	NULL
clones	NULL
were	NULL
isolated	NULL
,	NULL
they	NULL
do	NULL
not	NULL
extend	NULL
to	NULL
the	NULL
ends	NULL
of	NULL
Oct2	NULL
mRNA	NULL
.	NULL

Interestingly	NULL
,	NULL
all	NULL
the	NULL
Oct2	NULL
protein	NULL
encoding	NULL
information	NULL
extends	NULL
over	NULL
only	NULL
1.8kb	NULL
whereas	NULL
in	NULL
a	NULL
Northern	NULL
analysis	NULL
with	NULL
B-cell	NULL
RNA	NULL
,	NULL
several	NULL
poly	NULL
(	NULL
A	NULL
+	NULL
)	NULL
RNA	NULL
species	NULL
that	NULL
range	NULL
in	NULL
size	NULL
from	NULL
6.5	NULL
to	NULL
2kb	NULL
can	NULL
be	NULL
detected	NULL
(	NULL
27	NULL
,	NULL
28	NULL
,	NULL
38	NULL
)	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

At	NULL
present	NULL
,	NULL
it	NULL
is	NULL
unclear	NULL
A	NULL
1	NULL
11	NULL
if	NULL
]	NULL
]	NULL
1	NULL
1	NULL
u	NULL
Lig	NULL
_	NULL
--	NULL
pll	NULL
_	NULL
-	NULL
#	NULL
L	NULL
U	NULL
1	NULL
23	NULL
dab	NULL
56	NULL
Tak	NULL
8910	NULL
11	NULL
HMIS	NULL
14	NULL
=	NULL
B	NULL
cDNA	NULL
type	NULL
FR	NULL
800	NULL
O	NULL
eau	NULL
000	NULL
WRMCO	NULL
(	NULL
--	NULL
-3	NULL
«	NULL
»	NULL
«	NULL
ar	NULL
O00	NULL
(	NULL
--	NULL
1	NULL
»	NULL
oes	NULL
O00	NULL
E	NULL
@	NULL
E	NULL
@	NULL
OO	NULL
COCCOC	NULL
--	NULL
OOE	NULL
@	NULL
®DN	NULL
(	NULL
--	NULL
-ee	NULL
000	NULL
WESCO	NULL
OCOCOCOD	NULL
CG	NULL
oes	NULL
000	NULL
WEMOO	NULL
»	NULL
oes	NULL
000	NULL
CGO	NULL
-I14	NULL
mous	NULL
CC	NULL
08	NULL
POU-spec	NULL
POU-Homeo	NULL
LEU	NULL
Figure	NULL
2	NULL
:	NULL
Exon/Intron	NULL
structure	NULL
of	NULL
the	NULL
coding	NULL
region	NULL
of	NULL
the	NULL
mouse	NULL
Oct2	NULL
gene	NULL
.	NULL

A	NULL
.	NULL
)	NULL

The	NULL
restriction	NULL
map	NULL
of	NULL
about	NULL
50kb	NULL
genomic	NULL
DNA	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
sizes	NULL
of	NULL
the	NULL
exons	NULL
(	NULL
open	NULL
boxes	NULL
)	NULL
are	NULL
not	NULL
drawn	NULL
to	NULL
scale	NULL
.	NULL

a/b	NULL
indicates	NULL
that	NULL
due	NULL
to	NULL
the	NULL
use	NULL
of	NULL
alternative	NULL
splice	NULL
acceptors	NULL
different	NULL
parts	NULL
of	NULL
the	NULL
same	NULL
exon	NULL
are	NULL
present	NULL
in	NULL
different	NULL
cDNAs	NULL
.	NULL

B	NULL
.	NULL
)	NULL

Schematic	NULL
representation	NULL
of	NULL
the	NULL
exon	NULL
structure	NULL
of	NULL
the	NULL
six	NULL
Oct2	NULL
isoforms	NULL
.	NULL

The	NULL
top	NULL
line	NULL
shows	NULL
the	NULL
14	NULL
exons	NULL
utilized	NULL
by	NULL
the	NULL
various	NULL
forms	NULL
,	NULL
the	NULL
exon	NULL
composition	NULL
of	NULL
the	NULL
individual	NULL
isoforms	NULL
is	NULL
shown	NULL
below	NULL
.	NULL

The	NULL
regions	NULL
encoding	NULL
the	NULL
POU-specific	NULL
domain	NULL
,	NULL
the	NULL
POU	NULL
homeo	NULL
domain	NULL
and	NULL
the	NULL
putative	NULL
leucine	NULL
zipper	NULL
are	NULL
indicated	NULL
below	NULL
the	NULL
figure	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
translational	NULL
stop	NULL
codon	NULL
predicted	NULL
for	NULL
the	NULL
various	NULL
isoforms	NULL
is	NULL
shown	NULL
as	NULL
a	NULL
black	NULL
dot	NULL
above	NULL
the	NULL
respective	NULL
exon	NULL
,	NULL
the	NULL
length	NULL
of	NULL
each	NULL
of	NULL
the	NULL
proteins	NULL
(	NULL
starting	NULL
with	NULL
the	NULL
first	NULL
in	NULL
frame	NULL
AUG	NULL
)	NULL
is	NULL
given	NULL
to	NULL
the	NULL
right	NULL
of	NULL
every	NULL
isoform	NULL
.	NULL

whether	NULL
the	NULL
missing	NULL
extensions	NULL
are	NULL
attached	NULL
to	NULL
the	NULL
5	NULL
'	NULL
or	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
cloned	NULL
cDNAs	NULL
.	NULL

A	NULL
comparison	NULL
of	NULL
the	NULL
exon	NULL
sequences	NULL
of	NULL
the	NULL
genomic	NULL
and	NULL
cDNA	NULL
clones	NULL
revealed	NULL
that	NULL
the	NULL
two	NULL
in	NULL
frame	NULL
insertions	NULL
in	NULL
clones	NULL
Oct2.2	NULL
and	NULL
Oct2.3	NULL
as	NULL
well	NULL
as	NULL
Oct2.4	NULL
are	NULL
generated	NULL
by	NULL
using	NULL
alternative	NULL
splice	NULL
acceptor	NULL
sites	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
.	NULL

Oct2.6	NULL
is	NULL
generated	NULL
by	NULL
skipping	NULL
exon	NULL
4	NULL
.	NULL

The	NULL
74bp	NULL
insert	NULL
present	NULL
in	NULL
the	NULL
Oct2.5	NULL
isoform	NULL
represents	NULL
an	NULL
autonomous	NULL
miniexon	NULL
that	NULL
is	NULL
spliced	NULL
out	NULL
in	NULL
all	NULL
the	NULL
other	NULL
isoforms	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
.	NULL

Both	NULL
the	NULL
POU-specific	NULL
as	NULL
well	NULL
as	NULL
the	NULL
POU-homeo	NULL
domains	NULL
are	NULL
split	NULL
by	NULL
an	NULL
intron	NULL
(	NULL
Figures	NULL
1B	NULL
and	NULL
2B	NULL
)	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
intron	NULL
in	NULL
the	NULL
POU-specific	NULL
subdomain	NULL
does	NULL
not	NULL
correspond	NULL
to	NULL
the	NULL
short	NULL
stretch	NULL
of	NULL
amino	NULL
acids	NULL
that	NULL
separates	NULL
the	NULL
POU-A	NULL
and	NULL
the	NULL
POU-B	NULL
regions	NULL
(	NULL
35	NULL
)	NULL
but	NULL
rather	NULL
splits	NULL
the	NULL
POU-A	NULL
region	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
leucine	NULL
zipper	NULL
region	NULL
localized	NULL
3	NULL
'	NULL
to	NULL
the	NULL
POU-domain	NULL
is	NULL
also	NULL
split	NULL
by	NULL
an	NULL
intron	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

The	NULL
frequencies	NULL
with	NULL
which	NULL
the	NULL
different	NULL
isoforms	NULL
occurred	NULL
in	NULL
the	NULL
pool	NULL
of	NULL
cloned	NULL
cDNAs	NULL
indicated	NULL
that	NULL
they	NULL
might	NULL
not	NULL
be	NULL
present	NULL
in	NULL
equimolar	NULL
amounts	NULL
in	NULL
WEHI231	NULL
cells	NULL
.	NULL

Therefore	NULL
RNase	NULL
protection	NULL
assays	NULL
that	NULL
allowed	NULL
us	NULL
to	NULL
distinguish	NULL
between	NULL
the	NULL
different	NULL
Oct2	NULL
forms	NULL
were	NULL
performed	NULL
to	NULL
measure	NULL
their	NULL
relative	NULL
frequencies	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

We	NULL
were	NULL
readily	NULL
able	NULL
to	NULL
detect	NULL
the	NULL
appropriate	NULL
protected	NULL
fragments	NULL
for	NULL
isoforms	NULL
Oct2.2	NULL
,	NULL
Oct2.3	NULL
and	NULL
Oct2.5	NULL
as	NULL
well	NULL
as	NULL
Oct2.4	NULL
in	NULL
addition	NULL
to	NULL
Oct2.1	NULL
which	NULL
represents	NULL
the	NULL
dominant	NULL
form	NULL
in	NULL
WEHI231	NULL
RNA	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
and	NULL
3C	NULL
)	NULL
.	NULL

The	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

1	NULL
47	NULL
B	NULL
i	NULL
o-	NULL
ci-	NULL
«	NULL
i	NULL
=	NULL
&	NULL
£	NULL
622	NULL
al	NULL
*	NULL
«	NULL
aid	NULL
C	NULL
404	NULL
W	NULL
ugg	NULL
,	NULL
lied	NULL
Z	NULL
:	NULL
on	NULL
T	NULL
«	NULL
he	NULL
A	NULL
m	NULL
A	NULL
mo	NULL
3	NULL
G	NULL
m	NULL
4	NULL
m	NULL
309	NULL
_-	NULL
#	NULL
#	NULL
#	NULL
a=	NULL
R	NULL
a	NULL
m	NULL
``	NULL
w	NULL
a	NULL
**	NULL
622	NULL
52	NULL
217	NULL
-	NULL
wlth	NULL
c	NULL
404	NULL
201	NULL
1	NULL
A	NULL
3	NULL
TT	NULL
``	NULL
.	NULL

~	NULL
a	NULL
Z	NULL
Z	NULL
-	NULL
a.	NULL
ml	NULL
ﬂ	NULL
109	NULL
I	NULL
e	NULL
nog	NULL
g	NULL
e	NULL
s	NULL
|	NULL
180	NULL
_.	NULL
wwe	NULL
’	NULL
a	NULL
Oct2.3	NULL
~-	NULL
yrmat	NULL
3	NULL
--	NULL
-	NULL
160	NULL
-_-	NULL
«	NULL
with	NULL
199nt	NULL
112nt	NULL
242	NULL
(	NULL
Q	NULL
Oct2.2	NULL
392nt	NULL
147	NULL
ﬂ	NULL
217	NULL
208at	NULL
136nt	NULL
201	NULL
.	NULL

190	NULL
Oct2.5	NULL
491nt	NULL
180	NULL
229nt	NULL
188nt	NULL
171	NULL
w	NULL
110	NULL
-	NULL
|/	NULL
Q	NULL
160	NULL
|	NULL
}	NULL
|	NULL
|	NULL
}	NULL
is	NULL
Oct2.4	NULL
147	NULL
413nt	NULL
259nt	NULL
Figure	NULL
3	NULL
:	NULL
RNA	NULL
corresponding	NULL
to	NULL
the	NULL
different	NULL
isoforms	NULL
are	NULL
present	NULL
at	NULL
varying	NULL
levels	NULL
in	NULL
B-cells	NULL
.	NULL

A	NULL
.	NULL
)	NULL

Schematic	NULL
representation	NULL
of	NULL
the	NULL
fragments	NULL
that	NULL
are	NULL
predicted	NULL
to	NULL
be	NULL
protected	NULL
from	NULL
RNase	NULL
degradation	NULL
.	NULL

The	NULL
large	NULL
fragment	NULL
represents	NULL
the	NULL
Oct2	NULL
cDNA	NULL
fragment	NULL
subcloned	NULL
into	NULL
the	NULL
pBluescript	NULL
SK~	NULL
vector	NULL
used	NULL
to	NULL
generate	NULL
the	NULL
probe	NULL
.	NULL

The	NULL
actual	NULL
probe	NULL
size	NULL
is	NULL
50	NULL
to	NULL
6Ont	NULL
longer	NULL
than	NULL
the	NULL
size	NULL
of	NULL
the	NULL
largest	NULL
protected	NULL
fragment	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
polylinker	NULL
sequences	NULL
.	NULL

The	NULL
open	NULL
boxes	NULL
indicate	NULL
the	NULL
extra	NULL
sequences	NULL
present	NULL
in	NULL
the	NULL
Oct2.2	NULL
,	NULL
Oct2.3	NULL
and	NULL
Oct2.5	NULL
forms	NULL
,	NULL
respectively	NULL
,	NULL
the	NULL
black	NULL
box	NULL
indicates	NULL
the	NULL
region	NULL
missing	NULL
in	NULL
the	NULL
Oct2.4	NULL
cDNA	NULL
.	NULL

Correspondingly	NULL
for	NULL
Oct2.2	NULL
,	NULL
Oct2.3	NULL
and	NULL
Oct2.5	NULL
the	NULL
largest	NULL
protected	NULL
fragment	NULL
is	NULL
indicative	NULL
for	NULL
the	NULL
respective	NULL
RNA	NULL
whereas	NULL
in	NULL
the	NULL
case	NULL
of	NULL
Oct2.4	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
shorter	NULL
protected	NULL
fragment	NULL
is	NULL
indicative	NULL
for	NULL
the	NULL
respective	NULL
RNA	NULL
.	NULL

The	NULL
other	NULL
protected	NULL
fragments	NULL
are	NULL
indicative	NULL
for	NULL
all	NULL
the	NULL
Oct2	NULL
RNAs	NULL
except	NULL
the	NULL
specific	NULL
form	NULL
.	NULL

B	NULL
.	NULL
)	NULL

RNase	NULL
protection	NULL
with	NULL
the	NULL
Oct2.2	NULL
,	NULL
Oct2.3	NULL
and	NULL
Oct2.5	NULL
probes	NULL
using	NULL
3O0mg	NULL
cytoplasmic	NULL
WEHI231	NULL
RNA	NULL
.	NULL

The	NULL
marker	NULL
shown	NULL
in	NULL
the	NULL
left	NULL
lane	NULL
is	NULL
an	NULL
endlabelled	NULL
MspI	NULL
digest	NULL
of	NULL
pBR322	NULL
DNA	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
an	NULL
additional	NULL
fragment	NULL
corresponding	NULL
to	NULL
residual	NULL
undigested	NULL
probe	NULL
is	NULL
seen	NULL
above	NULL
the	NULL
largest	NULL
protected	NULL
fragment	NULL
.	NULL

C.	NULL
)	NULL
RNase	NULL
protection	NULL
with	NULL
the	NULL
Oct2.4	NULL
probe	NULL
and	NULL
RNA	NULL
isolated	NULL
from	NULL
either	NULL
WEHI231	NULL
cells	NULL
,	NULL
total	NULL
spleen	NULL
(	NULL
504g	NULL
each	NULL
)	NULL
or	NULL
NIH/3T3	NULL
cells	NULL
stably	NULL
transformed	NULL
with	NULL
an	NULL
Oct2.4	NULL
expression	NULL
construct	NULL
(	NULL
204g	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
correct	NULL
protected	NULL
fragments	NULL
are	NULL
indicated	NULL
by	NULL
arrowheads	NULL
.	NULL

As	NULL
the	NULL
stably	NULL
transformed	NULL
cells	NULL
only	NULL
express	NULL
Oct2.4	NULL
the	NULL
large	NULL
protected	NULL
fragment	NULL
indicative	NULL
for	NULL
the	NULL
forms	NULL
Oct2.1-3	NULL
and	NULL
Oct2.5-6	NULL
is	NULL
absent	NULL
in	NULL
this	NULL
lane	NULL
.	NULL

two	NULL
larger	NULL
fragments	NULL
in	NULL
the	NULL
Oct2.5	NULL
specific	NULL
protection	NULL
experiment	NULL
show	NULL
a	NULL
somewhat	NULL
aberrant	NULL
running	NULL
behavior	NULL
by	NULL
migrating	NULL
too	NULL
slowly	NULL
in	NULL
the	NULL
gel	NULL
system	NULL
used	NULL
(	NULL
even	NULL
more	NULL
pronounced	NULL
in	NULL
Figure	NULL
6	NULL
,	NULL
see	NULL
below	NULL
)	NULL
.	NULL

These	NULL
bands	NULL
represent	NULL
the	NULL
correct	NULL
protected	NULL
fragments	NULL
,	NULL
however	NULL
,	NULL
as	NULL
comigrating	NULL
bands	NULL
were	NULL
specifically	NULL
obtained	NULL
by	NULL
RNase	NULL
protection	NULL
using	NULL
RNA	NULL
from	NULL
fibroblast	NULL
cells	NULL
transfected	NULL
with	NULL
either	NULL
Oct2.1	NULL
or	NULL
Oct2.5	NULL
cDNA	NULL
expression	NULL
constructs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
,	NULL
for	NULL
structure	NULL
of	NULL
the	NULL
expression	NULL
constructs	NULL
see	NULL
Figure	NULL
5A	NULL
)	NULL
.	NULL

RNA	NULL
corresponding	NULL
to	NULL
isoform	NULL
Oct2.6	NULL
could	NULL
only	NULL
be	NULL
detected	NULL
using	NULL
a	NULL
PCR	NULL
protocol	NULL
and	NULL
an	NULL
amplification	NULL
primer	NULL
specific	NULL
for	NULL
the	NULL
indicative	NULL
junction	NULL
of	NULL
the	NULL
Oct2.6	NULL
cDNA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

From	NULL
densitometric	NULL
scanning	NULL
of	NULL
the	NULL
autoradiographs	NULL
in	NULL
Figure	NULL
3B	NULL
and	NULL
3C	NULL
we	NULL
calculate	NULL
that	NULL
Oct2.2	NULL
is	NULL
present	NULL
at	NULL
a	NULL
frequency	NULL
of	NULL
roughly	NULL
5	NULL
%	NULL
of	NULL
total	NULL
Oct2	NULL
RNA	NULL
whereas	NULL
Oct2.3	NULL
and	NULL
Oct2.5	NULL
make	NULL
up	NULL
about	NULL
11	NULL
%	NULL
and	NULL
18	NULL
%	NULL
of	NULL
the	NULL
Oct2	NULL
RNA	NULL
,	NULL
respectively	NULL
.	NULL

Oct2.4	NULL
represents	NULL
about	NULL
8	NULL
%	NULL
and	NULL
Oct2.6	NULL
is	NULL
very	NULL
infrequent	NULL
making	NULL
up	NULL
less	NULL
than	NULL
1	NULL
%	NULL
of	NULL
the	NULL
Oct2	NULL
RNA	NULL
.	NULL

From	NULL
these	NULL
numbers	NULL
we	NULL
estimate	NULL
that	NULL
Oct2.1	NULL
makes	NULL
up	NULL
about	NULL
55	NULL
%	NULL
and	NULL
therefore	NULL
represents	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
Oct2	NULL
RNA	NULL
present	NULL
in	NULL
WEHI231	NULL
cells	NULL
.	NULL

These	NULL
numbers	NULL
are	NULL
good	NULL
reflections	NULL
of	NULL
the	NULL
frequencies	NULL
with	NULL
which	NULL
the	NULL
clones	NULL
were	NULL
originally	NULL
detected	NULL
in	NULL
the	NULL
PCR	NULL
cloning	NULL
protocol	NULL
(	NULL
with	NULL
the	NULL
noted	NULL
exception	NULL
of	NULL
Oct2.6	NULL
)	NULL
arguing	NULL
for	NULL
the	NULL
general	NULL
validity	NULL
of	NULL
the	NULL
approach	NULL
.	NULL

Oct2	NULL
isoforms	NULL
are	NULL
functional	NULL
transcription	NULL
factors	NULL
The	NULL
deduced	NULL
amino	NULL
acid	NULL
sequences	NULL
shown	NULL
in	NULL
Figure	NULL
!	NULL

suggest	NULL
that	NULL
the	NULL
different	NULL
isoforms	NULL
encode	NULL
proteins	NULL
of	NULL
quite	NULL
distinct	NULL
sizes	NULL
.	NULL

This	NULL
was	NULL
verified	NULL
both	NULL
by	NULL
overexpression	NULL
of	NULL
the	NULL
individual	NULL
isoforms	NULL
in	NULL
a	NULL
bacterial	NULL
expression	NULL
system	NULL
as	NULL
well	NULL
as	NULL
by	NULL
in	NULL
vitro	NULL
translation	NULL
in	NULL
reticulocyte	NULL
lysates	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

When	NULL
used	NULL
in	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
specific	NULL
complexes	NULL
with	NULL
an	NULL
octamer	NULL
containing	NULL
probe	NULL
were	NULL
obtained	NULL
with	NULL
all	NULL
six	NULL
isoforms	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

A	NULL
comparison	NULL
of	NULL
the	NULL
retarded	NULL
complexes	NULL
48	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

1	NULL
Oct1	NULL
Oct2B	NULL
Oct2A	NULL
ns	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
Figure	NULL
4	NULL
:	NULL
In	NULL
vitro	NULL
synthesized	NULL
Oct2	NULL
proteins	NULL
specifically	NULL
bind	NULL
to	NULL
the	NULL
octamer	NULL
motif	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
with	NULL
221	NULL
aliquots	NULL
of	NULL
the	NULL
in	NULL
vitro	NULL
translation	NULL
reactions	NULL
(	NULL
lanes	NULL
1-14	NULL
)	NULL
or	NULL
a	NULL
BJA-B	NULL
nuclear	NULL
extract	NULL
(	NULL
lanes	NULL
15,16	NULL
)	NULL
.	NULL

A	NULL
radiolabelled	NULL
probe	NULL
containing	NULL
either	NULL
a	NULL
wild	NULL
type	NULL
(	NULL
odd	NULL
numbered	NULL
lanes	NULL
)	NULL
or	NULL
mutant	NULL
octamer	NULL
motif	NULL
(	NULL
even	NULL
numbered	NULL
lanes	NULL
)	NULL
was	NULL
used	NULL
.	NULL

In	NULL
vitro	NULL
translation	NULL
without	NULL
added	NULL
RNA	NULL
(	NULL
lanes	NULL
1,2	NULL
)	NULL
,	NULL
Oct2.1	NULL
(	NULL
lanes	NULL
3,4	NULL
)	NULL
,	NULL
Oct2.2	NULL
(	NULL
lanes	NULL
5,6	NULL
)	NULL
,	NULL
Oct2.3	NULL
(	NULL
lanes	NULL
7,8	NULL
)	NULL
,	NULL
Oct2.4	NULL
(	NULL
lanes	NULL
9,10	NULL
)	NULL
,	NULL
Oct2.5	NULL
(	NULL
lanes	NULL
11,12	NULL
)	NULL
or	NULL
Oct2.6	NULL
(	NULL
lanes	NULL
13,14	NULL
)	NULL
RNA	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
known	NULL
Oct2	NULL
shifts	NULL
(	NULL
Oct1	NULL
,	NULL
Oct2B	NULL
and	NULL
Oct2A	NULL
)	NULL
and	NULL
the	NULL
free	NULL
probe	NULL
(	NULL
F	NULL
)	NULL
are	NULL
marked	NULL
.	NULL

The	NULL
complex	NULL
migrating	NULL
ahead	NULL
of	NULL
the	NULL
Oct2A	NULL
shift	NULL
in	NULL
the	NULL
lanes	NULL
with	NULL
the	NULL
BJA-B	NULL
nuclear	NULL
extract	NULL
is	NULL
most	NULL
likely	NULL
a	NULL
non-specific	NULL
complex	NULL
,	NULL
because	NULL
it	NULL
is	NULL
also	NULL
detectable	NULL
with	NULL
the	NULL
mutant	NULL
octamer	NULL
probe	NULL
.	NULL

with	NULL
those	NULL
obtained	NULL
with	NULL
a	NULL
control	NULL
BJA-B	NULL
nuclear	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
15	NULL
and	NULL
16	NULL
)	NULL
indicates	NULL
that	NULL
the	NULL
proteins	NULL
encoded	NULL
by	NULL
Oct2.1	NULL
,	NULL
Oct2.2	NULL
and	NULL
Oct2.3	NULL
all	NULL
shift	NULL
the	NULL
wild-type	NULL
probe	NULL
to	NULL
a	NULL
position	NULL
similar	NULL
to	NULL
the	NULL
Oct2A	NULL
complex	NULL
present	NULL
in	NULL
BJA-B	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
3,5,7	NULL
and	NULL
15	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
the	NULL
previous	NULL
designation	NULL
Oct2A	NULL
does	NULL
not	NULL
describe	NULL
a	NULL
single	NULL
protein	NULL
but	NULL
rather	NULL
a	NULL
family	NULL
of	NULL
similar	NULL
sized	NULL
proteins	NULL
.	NULL

The	NULL
Oct2.5	NULL
protein	NULL
shifts	NULL
the	NULL
probe	NULL
to	NULL
a	NULL
position	NULL
that	NULL
corresponds	NULL
to	NULL
the	NULL
position	NULL
of	NULL
the	NULL
Oct2B	NULL
band	NULL
shift	NULL
(	NULL
compare	NULL
lanes	NULL
11	NULL
and	NULL
15	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

This	NULL
comigration	NULL
is	NULL
still	NULL
observed	NULL
when	NULL
the	NULL
gels	NULL
are	NULL
run	NULL
much	NULL
further	NULL
to	NULL
yield	NULL
a	NULL
higher	NULL
resolution	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
comigration	NULL
in	NULL
the	NULL
EMSA	NULL
together	NULL
with	NULL
the	NULL
observed	NULL
size	NULL
of	NULL
Oct2.5	NULL
in	NULL
the	NULL
SDS-polyacrylamide	NULL
gel	NULL
strongly	NULL
suggests	NULL
that	NULL
Oct2.5	NULL
encodes	NULL
the	NULL
previously	NULL
described	NULL
Oct2B	NULL
protein	NULL
.	NULL

Oct2.4	NULL
and	NULL
Oct2.6	NULL
protein-DNA	NULL
complexes	NULL
migrate	NULL
faster	NULL
than	NULL
the	NULL
Oct2A	NULL
protein-DNA	NULL
complexes	NULL
and	NULL
have	NULL
not	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
9	NULL
and	NULL
13	NULL
)	NULL
.	NULL

There	NULL
is	NULL
a	NULL
complex	NULL
of	NULL
similar	NULL
mobility	NULL
visible	NULL
with	NULL
the	NULL
BJA-B	NULL
extract	NULL
used	NULL
.	NULL

However	NULL
,	NULL
this	NULL
complex	NULL
is	NULL
not	NULL
specific	NULL
for	NULL
the	NULL
wild-tpye	NULL
octamer	NULL
probe	NULL
,	NULL
because	NULL
it	NULL
is	NULL
also	NULL
present	NULL
when	NULL
the	NULL
mutant	NULL
probe	NULL
is	NULL
used	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
15	NULL
and	NULL
16	NULL
)	NULL
.	NULL

A	NULL
specific	NULL
complex	NULL
that	NULL
could	NULL
potentialy	NULL
comigrate	NULL
with	NULL
the	NULL
Oct2.4/Oct2.6	NULL
protein-DNA	NULL
complexes	NULL
termed	NULL
Oct2C	NULL
is	NULL
observed	NULL
in	NULL
some	NULL
BJA-B	NULL
nuclear	NULL
extract	NULL
preparations	NULL
,	NULL
however	NULL
(	NULL
E.	NULL
Schreiber	NULL
,	NULL
pers	NULL
.	NULL

communication	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
might	NULL
be	NULL
hidden	NULL
underneath	NULL
the	NULL
non-specific	NULL
shift	NULL
present	NULL
in	NULL
our	NULL
extracts	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
the	NULL
different	NULL
Oct2	NULL
isoforms	NULL
to	NULL
activate	NULL
transcription	NULL
was	NULL
tested	NULL
in	NULL
a	NULL
cotransfection	NULL
assay	NULL
.	NULL

The	NULL
human	NULL
Oct2A	NULL
cDNA	NULL
(	NULL
corresponding	NULL
to	NULL
our	NULL
Oct2.2	NULL
isoform	NULL
)	NULL
had	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
able	NULL
to	NULL
stimulate	NULL
an	NULL
octamer	NULL
promoter	NULL
construct	NULL
in	NULL
non-lymphoid	NULL
cells	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Oct2	NULL
cDNAs	NULL
were	NULL
introduced	NULL
into	NULL
a	NULL
cytomegalovirus	NULL
enhancer/promoter	NULL
based	NULL
CMV	NULL
Oct2.1	NULL
-	NULL
Oct2.6	NULL
cDNA	NULL
SV40	NULL
t-splice/poly	NULL
A	NULL
EE	NULL
]	NULL
``	NULL
``	NULL
iy	NULL
promoter	NULL
mouse/human	NULL
beta	NULL
globin	NULL
$	NULL
V40	NULL
Enh	NULL
C	NULL
E44	NULL
-	NULL
Z	NULL
H	NULL
]	NULL
4	NULL
=	NULL
--	NULL
-A-	NULL
_de	NULL
2100	NULL
GTCGACTCTAGAGGATCATGCAAATGATCCCCGATCTGGGGCAGAGCATATAAGGTGAGG	NULL
I	NULL
GTCGACTCTAGAGGATCATTCAAATGATCCCCGATCTGGGGCAGAGCATATAAGGTGAGG	NULL
primer	NULL
1020	NULL
3	NULL
4	NULL
50	NULL
6	NULL
708	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
H4	NULL
Figure	NULL
5	NULL
:	NULL
The	NULL
various	NULL
Oct2	NULL
isoforms	NULL
can	NULL
activate	NULL
an	NULL
octamer	NULL
containing	NULL
promoter	NULL
.	NULL

A	NULL
.	NULL
)	NULL

Scheme	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
enhancer/promoter	NULL
Oct2	NULL
expression	NULL
constructs	NULL
and	NULL
the	NULL
reporter	NULL
plasmids	NULL
.	NULL

The	NULL
reporter	NULL
plasmids	NULL
also	NULL
contained	NULL
the	NULL
polyoma	NULL
virus	NULL
early	NULL
region	NULL
to	NULL
allow	NULL
for	NULL
replication	NULL
in	NULL
mouse	NULL
cells	NULL
and	NULL
modified	NULL
mouse	NULL
histone	NULL
H4	NULL
gene	NULL
used	NULL
as	NULL
a	NULL
reference	NULL
to	NULL
control	NULL
for	NULL
differences	NULL
in	NULL
the	NULL
transfection	NULL
efficiencies	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
(	NULL
top	NULL
)	NULL
and	NULL
mutant	NULL
(	NULL
bottom	NULL
)	NULL
octamer	NULL
promoters	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
octamer	NULL
element	NULL
and	NULL
the	NULL
TAT	NULL
A-motif	NULL
in	NULL
the	NULL
promoter	NULL
are	NULL
highlighted	NULL
,	NULL
the	NULL
position	NULL
of	NULL
the	NULL
point	NULL
mutation	NULL
in	NULL
the	NULL
octamer	NULL
element	NULL
is	NULL
indicated	NULL
.	NULL

B	NULL
.	NULL
)	NULL

Primer	NULL
extension/nuclease	NULL
S1	NULL
analysis	NULL
of	NULL
RNA	NULL
form	NULL
NIH/3T3	NULL
cells	NULL
co-tranfected	NULL
with	NULL
the	NULL
various	NULL
Oct2	NULL
expression	NULL
constructs	NULL
(	NULL
Oct2.1	NULL
,	NULL
lanes	NULL
1,2	NULL
;	NULL
Oct2.2	NULL
,	NULL
lanes	NULL
3,4	NULL
;	NULL
Oct2.3	NULL
,	NULL
lanes	NULL
5,6	NULL
;	NULL
Oct2.4	NULL
,	NULL
lanes	NULL
7,8	NULL
;	NULL
Oct2.5	NULL
,	NULL
lanes	NULL
9,10	NULL
;	NULL
Oct2.6	NULL
,	NULL
lanes	NULL
11,12	NULL
)	NULL
or	NULL
the	NULL
expression	NULL
vector	NULL
without	NULL
an	NULL
Oct2	NULL
cDNA	NULL
insert	NULL
(	NULL
lanes	NULL
13,14	NULL
)	NULL
©	NULL
and	NULL
either	NULL
the	NULL
wild	NULL
type	NULL
(	NULL
odd	NULL
numbered	NULL
lanes	NULL
)	NULL
or	NULL
mutant	NULL
(	NULL
even	NULL
numbered	NULL
lanes	NULL
)	NULL
octamer	NULL
promoter	NULL
reporter	NULL
constructs	NULL
.	NULL

The	NULL
upper	NULL
panel	NULL
shows	NULL
the	NULL
-globin	NULL
primer	NULL
extension	NULL
analysis	NULL
,	NULL
the	NULL
lower	NULL
panel	NULL
shows	NULL
the	NULL
nuclease	NULL
S1	NULL
analysis	NULL
specific	NULL
for	NULL
the	NULL
histone	NULL
H4	NULL
reference	NULL
.	NULL

Positions	NULL
of	NULL
the	NULL
correct	NULL
fragments	NULL
for	NULL
the	NULL
H4	NULL
and	NULL
globin	NULL
analyses	NULL
as	NULL
well	NULL
as	NULL
the	NULL
primer	NULL
are	NULL
marked	NULL
.	NULL

Additional	NULL
bands	NULL
visible	NULL
above	NULL
the	NULL
correctly	NULL
extended	NULL
fragment	NULL
in	NULL
the	NULL
3-globin	NULL
primer	NULL
extension	NULL
analysis	NULL
most	NULL
likely	NULL
originate	NULL
from	NULL
readthrough	NULL
transcription	NULL
of	NULL
the	NULL
replicating	NULL
plasmids	NULL
.	NULL

eukaryotic	NULL
expression	NULL
vector	NULL
.	NULL

The	NULL
AUG	NULL
codon	NULL
was	NULL
provided	NULL
by	NULL
the	NULL
vector	NULL
and	NULL
6	NULL
amino	NULL
acids	NULL
encoded	NULL
by	NULL
the	NULL
vector	NULL
polylinker	NULL
replaced	NULL
the	NULL
first	NULL
two	NULL
amino	NULL
acids	NULL
of	NULL
Oct2	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

The	NULL
reporter	NULL
plasmids	NULL
containing	NULL
either	NULL
a	NULL
wild-type	NULL
or	NULL
a	NULL
point	NULL
mutant	NULL
version	NULL
of	NULL
the	NULL
octamer	NULL
motif	NULL
upstream	NULL
of	NULL
the	NULL
-globin	NULL
TATA-box	NULL
and	NULL
the	NULL
modified	NULL
3-globin	NULL
gene	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
reporter	NULL
plasmids	NULL
also	NULL
contain	NULL
a	NULL
modified	NULL
mouse	NULL
histone	NULL
H4	NULL
gene	NULL
that	NULL
allows	NULL
correction	NULL
for	NULL
different	NULL
transfection	NULL
efficiencies	NULL
.	NULL

NIH/3T3	NULL
fibroblast	NULL
cells	NULL
were	NULL
cotransfected	NULL
and	NULL
RNA	NULL
was	NULL
isolated	NULL
for	NULL
quantitative	NULL
analysis	NULL
48hrs	NULL
later	NULL
.	NULL

From	NULL
the	NULL
results	NULL
obtained	NULL
it	NULL
is	NULL
evident	NULL
that	NULL
all	NULL
6	NULL
isoforms	NULL
can	NULL
stimulate	NULL
the	NULL
wild-type	NULL
octamer	NULL
promoter	NULL
construct	NULL
whereas	NULL
the	NULL
constructs	NULL
containing	NULL
a	NULL
mutant	NULL
octamer	NULL
motif	NULL
remain	NULL
unaffected	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
1-12	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
it	NULL
is	NULL
obvious	NULL
that	NULL
the	NULL
stimulation	NULL
depends	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
Oct	NULL
cDNA	NULL
because	NULL
a	NULL
control	NULL
cotransfection	NULL
with	NULL
the	NULL
expression	NULL
vector	NULL
lacking	NULL
an	NULL
Oct2	NULL
cDNA	NULL
insert	NULL
does	NULL
not	NULL
give	NULL
this	NULL
stimulatory	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
13,14	NULL
)	NULL
.	NULL

Oct2	NULL
splicing	NULL
pattern	NULL
is	NULL
conserved	NULL
in	NULL
murine	NULL
B-cell	NULL
development	NULL
and	NULL
also	NULL
between	NULL
species	NULL
The	NULL
various	NULL
Oct2	NULL
isotypes	NULL
had	NULL
all	NULL
been	NULL
isolated	NULL
from	NULL
the	NULL
WEHI231	NULL
cell	NULL
line	NULL
which	NULL
represents	NULL
a	NULL
surface	NULL
immunoglobulin	NULL
positive	NULL
B-cell	NULL
.	NULL

It	NULL
was	NULL
of	NULL
interest	NULL
to	NULL
determine	NULL
whether	NULL
B-cells	NULL
at	NULL
other	NULL
differentiation	NULL
stages	NULL
would	NULL
express	NULL
the	NULL
same	NULL
set	NULL
of	NULL
Oct2	NULL
isoforms	NULL
or	NULL
whether	NULL
there	NULL
would	NULL
be	NULL
developmental	NULL
stage	NULL
specific	NULL
alternative	NULL
splicing	NULL
of	NULL
Oct	NULL
``	NULL
?	NULL

mRNA	NULL
.	NULL

As	NULL
representatives	NULL
of	NULL
different	NULL
stages	NULL
of	NULL
the	NULL
B-cell	NULL
lineage	NULL
we	NULL
chose	NULL
the	NULL
HAFTL	NULL
I	NULL
,	NULL
707/3	NULL
(	NULL
early	NULL
and	NULL
late	NULL
pre	NULL
B-cells	NULL
,	NULL
resp	NULL
.	NULL
)	NULL

,	NULL
WEHI231	NULL
(	NULL
mature	NULL
B-cells	NULL
)	NULL
and	NULL
X63Ag8/653	NULL
(	NULL
plasma	NULL
cells	NULL
)	NULL
cell	NULL
lines	NULL
.	NULL

RNase	NULL
protection	NULL
analysis	NULL
of	NULL
cytoplasmic	NULL
RNA	NULL
from	NULL
the	NULL
different	NULL
cell	NULL
lines	NULL
with	NULL
probes	NULL
detecting	NULL
Oct2.2	NULL
,	NULL
Oct2.3	NULL
and	NULL
Oct2.5	NULL
in	NULL
addition	NULL
to	NULL
Oct2	NULL
.	NULL

1	NULL
clearly	NULL
shows	NULL
that	NULL
the	NULL
Oct2	NULL
splicing	NULL
pattern	NULL
is	NULL
conserved	NULL
throughout	NULL
the	NULL
B-cell	NULL
lineage	NULL
(	NULL
Figure	NULL
6A	NULL
)	NULL
.	NULL

Furthermore	NULL
it	NULL
is	NULL
evident	NULL
that	NULL
although	NULL
the	NULL
overall	NULL
quantities	NULL
of	NULL
Oct2	NULL
RNA	NULL
are	NULL
lower	NULL
in	NULL
the	NULL
cell	NULL
lines	NULL
representing	NULL
the	NULL
earlier	NULL
stages	NULL
of	NULL
B-cell	NULL
development	NULL
,	NULL
the	NULL
relative	NULL
frequencies	NULL
of	NULL
the	NULL
individual	NULL
isoforms	NULL
are	NULL
roughly	NULL
the	NULL
same	NULL
in	NULL
all	NULL
cell	NULL
lines	NULL
tested	NULL
.	NULL

The	NULL
same	NULL
result	NULL
was	NULL
obtained	NULL
when	NULL
a	NULL
probe	NULL
specific	NULL
for	NULL
Oct2.4	NULL
was	NULL
used	NULL
or	NULL
PCR	NULL
analysis	NULL
with	NULL
an	NULL
Oct2.6	NULL
specific	NULL
primer	NULL
was	NULL
performed	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
also	NULL
analyzed	NULL
Oct2	NULL
expression	NULL
in	NULL
different	NULL
lymphoid	NULL
organs	NULL
to	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
observed	NULL
alternative	NULL
splicing	NULL
is	NULL
the	NULL
consequence	NULL
of	NULL
continuous	NULL
growth	NULL
of	NULL
cells	NULL
in	NULL
culture	NULL
.	NULL

RNase	NULL
protection	NULL
analysis	NULL
of	NULL
total	NULL
RNA	NULL
isolated	NULL
from	NULL
bone	NULL
marrow	NULL
,	NULL
thymus	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
mitogen	NULL
stimulated	NULL
spleen	NULL
cells	NULL
reveals	NULL
that	NULL
in	NULL
all	NULL
these	NULL
primary	NULL
samples	NULL
the	NULL
multitude	NULL
of	NULL
Oct2	NULL
isoform	NULL
expression	NULL
is	NULL
conserved	NULL
(	NULL
Figure	NULL
6B	NULL
)	NULL
.	NULL

Again	NULL
the	NULL
relative	NULL
frequencies	NULL
of	NULL
different	NULL
Oct2	NULL
isoforms	NULL
are	NULL
comparable	NULL
whereas	NULL
the	NULL
overall	NULL
amounts	NULL
of	NULL
Oct2	NULL
RNA	NULL
vary	NULL
in	NULL
the	NULL
different	NULL
organs	NULL
.	NULL

The	NULL
detection	NULL
of	NULL
the	NULL
full	NULL
range	NULL
of	NULL
Oct2	NULL
isotypes	NULL
in	NULL
bone	NULL
marrow	NULL
RNA	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
previous	NULL
observation	NULL
that	NULL
pro	NULL
and	NULL
pre	NULL
B-cell	NULL
lines	NULL
already	NULL
express	NULL
the	NULL
various	NULL
Oct2	NULL
isoforms	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
Oct2	NULL
RNA	NULL
in	NULL
thymus	NULL
and	NULL
ConA	NULL
stimulated	NULL
spleen	NULL
cells	NULL
suggests	NULL
that	NULL
primary	NULL
T-cells	NULL
actually	NULL
express	NULL
Oct2	NULL
.	NULL

Clearly	NULL
the	NULL
strongest	NULL
expression	NULL
of	NULL
Oct2	NULL
is	NULL
observed	NULL
in	NULL
spleen	NULL
and	NULL
lipopolysaccaride	NULL
(	NULL
LPS	NULL
)	NULL
stimulated	NULL
spleen	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
interesting	NULL
that	NULL
mitogen	NULL
stimulation	NULL
does	NULL
not	NULL
lead	NULL
to	NULL
a	NULL
significant	NULL
increase	NULL
of	NULL
Oct2	NULL
RNA	NULL
expression	NULL
.	NULL

The	NULL
previous	NULL
isolation	NULL
of	NULL
two	NULL
Oct2A	NULL
cDNAs	NULL
from	NULL
the	NULL
human	NULL
BJA-B	NULL
cell	NULL
line	NULL
corresponding	NULL
to	NULL
the	NULL
mouse	NULL
Oct2.1	NULL
and	NULL
Oct2.2	NULL
isoforms	NULL
indicated	NULL
that	NULL
the	NULL
alternative	NULL
splicing	NULL
pattern	NULL
is	NULL
conserved	NULL
even	NULL
between	NULL
mouse	NULL
and	NULL
human	NULL
.	NULL

To	NULL
further	NULL
extend	NULL
this	NULL
observation	NULL
we	NULL
investigated	NULL
whether	NULL
the	NULL
mouse	NULL
Oct2.5/0ct2B	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

1	NULL
49	NULL
62	NULL
w	NULL
hall	NULL
=	NULL
=	NULL
``	NULL
``	NULL
201	NULL
103.	NULL
ym	NULL
7	NULL
$	NULL
C010	NULL
``	NULL
IP	NULL
``	NULL
32	NULL
033	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
19	NULL
Figure	NULL
6	NULL
:	NULL
Expression	NULL
of	NULL
Oct2	NULL
isoforms	NULL
in	NULL
different	NULL
B-cell	NULL
lines	NULL
and	NULL
lymphoid	NULL
organs	NULL
.	NULL

A	NULL
.	NULL
)	NULL

RNase	NULL
protection	NULL
analysis	NULL
with	NULL
the	NULL
Oct2.2	NULL
(	NULL
lanes	NULL
2-5	NULL
)	NULL
,	NULL
Oct2.3	NULL
(	NULL
lanes	NULL
7-10	NULL
)	NULL
and	NULL
Oct2.5	NULL
(	NULL
lanes	NULL
12-15	NULL
)	NULL
specific	NULL
probes	NULL
.	NULL

3Oug	NULL
cytoplasmic	NULL
RNA	NULL
from	NULL
HAFTL/I	NULL
(	NULL
lanes	NULL
2,7,12	NULL
)	NULL
,	NULL
702/3	NULL
(	NULL
lanes	NULL
3,8,13	NULL
)	NULL
,	NULL
WEHI231	NULL
(	NULL
lanes	NULL
4,9,14	NULL
)	NULL
and	NULL
X63Ag8/653	NULL
cells	NULL
(	NULL
lanes	NULL
5,10,15	NULL
)	NULL
were	NULL
used	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
correct	NULL
protected	NULL
fragments	NULL
is	NULL
indicated	NULL
by	NULL
arrowheads	NULL
.	NULL

The	NULL
marker	NULL
lanes	NULL
are	NULL
endlabelled	NULL
MspI	NULL
digests	NULL
of	NULL
pBR322	NULL
DNA	NULL
.	NULL

B	NULL
.	NULL
)	NULL

RNase	NULL
protection	NULL
analysis	NULL
with	NULL
RNA	NULL
from	NULL
various	NULL
organs	NULL
.	NULL

The	NULL
same	NULL
probes	NULL
as	NULL
above	NULL
were	NULL
used	NULL
(	NULL
Oct2.2	NULL
:	NULL
lanes	NULL
2-7	NULL
;	NULL
Oct2.3	NULL
:	NULL
lanes	NULL
8-13	NULL
;	NULL
Oct2.5	NULL
:	NULL
lanes	NULL
14-19	NULL
)	NULL
.	NULL

254g	NULL
of	NULL
cytoplasmic	NULL
WEHI231	NULL
RNA	NULL
(	NULL
lanes	NULL
2,8	NULL
,	NULL
14	NULL
)	NULL
or	NULL
504g	NULL
total	NULL
RNA	NULL
from	NULL
the	NULL
following	NULL
sources	NULL
were	NULL
used	NULL
:	NULL
bone	NULL
marrow	NULL
:	NULL
lanes	NULL
3.9.15	NULL
;	NULL
thymus	NULL
:	NULL
4,10,16	NULL
;	NULL
spleen	NULL
:	NULL
lanes	NULL
5,11,17	NULL
;	NULL
spleen/LPS	NULL
:	NULL
lanes	NULL
6,12,18	NULL
;	NULL
spleen/ConA	NULL
:	NULL
lanes	NULL
7,13,19	NULL
;	NULL
50	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

1	NULL
68kD	NULL
Figure	NULL
7	NULL
:	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
anti-Oct2	NULL
antisera	NULL
.	NULL

of	NULL
nuclear	NULL
proteins	NULL
from	NULL
BJA-B	NULL
(	NULL
lanes	NULL
1,2	NULL
)	NULL
and	NULL
WEHI231	NULL
cells	NULL
(	NULL
lanes	NULL
3,4	NULL
)	NULL
were	NULL
reacted	NULL
either	NULL
with	NULL
an	NULL
anti-Oct2.4	NULL
(	NULL
lanes	NULL
1,4	NULL
)	NULL
or	NULL
an	NULL
anti-Oct2.5	NULL
antiserum	NULL
.	NULL

Positions	NULL
of	NULL
the	NULL
molecular	NULL
weight	NULL
markers	NULL
are	NULL
marked	NULL
.	NULL

is	NULL
identical	NULL
to	NULL
the	NULL
human	NULL
Oct2B	NULL
.	NULL

We	NULL
raised	NULL
polyclonal	NULL
mouse	NULL
antibodies	NULL
against	NULL
bacterially	NULL
expressed	NULL
Oct2.4	NULL
and	NULL
Oct2.5	NULL
proteins	NULL
and	NULL
used	NULL
these	NULL
antisera	NULL
on	NULL
Western	NULL
blots	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
BJA-B	NULL
and	NULL
WEHI231	NULL
cells	NULL
.	NULL

Both	NULL
antisera	NULL
detect	NULL
several	NULL
proteins	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
two	NULL
cell	NULL
lines	NULL
clearly	NULL
indicating	NULL
that	NULL
the	NULL
pattern	NULL
of	NULL
alternatively	NULL
spliced	NULL
mRNAs	NULL
is	NULL
actually	NULL
mirrored	NULL
at	NULL
the	NULL
protein	NULL
level	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

The	NULL
pattern	NULL
is	NULL
slightly	NULL
different	NULL
between	NULL
the	NULL
two	NULL
cell	NULL
lines	NULL
,	NULL
however	NULL
,	NULL
and	NULL
it	NULL
is	NULL
presently	NULL
unclear	NULL
whether	NULL
this	NULL
reflects	NULL
species	NULL
specific	NULL
differences	NULL
or	NULL
whether	NULL
it	NULL
is	NULL
specific	NULL
for	NULL
the	NULL
cell	NULL
lines	NULL
chosen	NULL
.	NULL

The	NULL
protein	NULL
pattern	NULL
detected	NULL
with	NULL
the	NULL
two	NULL
anti-Oct	NULL
antisera	NULL
also	NULL
shows	NULL
some	NULL
pronounced	NULL
differences	NULL
,	NULL
namely	NULL
the	NULL
antiserum	NULL
raised	NULL
against	NULL
Oct2.5	NULL
reacts	NULL
much	NULL
stronger	NULL
against	NULL
a	NULL
75kD	NULL
band	NULL
in	NULL
both	NULL
BJA-B	NULL
and	NULL
WEHI	NULL
231	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
with	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

This	NULL
is	NULL
highly	NULL
suggestive	NULL
evidence	NULL
that	NULL
Oct2.5	NULL
in	NULL
fact	NULL
is	NULL
encoding	NULL
the	NULL
protein	NULL
that	NULL
had	NULL
previously	NULL
been	NULL
denoniinated	NULL
Oct2B	NULL
and	NULL
that	NULL
the	NULL
two	NULL
proteins	NULL
are	NULL
conserved	NULL
between	NULL
mouse	NULL
and	NULL
human	NULL
.	NULL

DISCUSSION	NULL
We	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
Iymphoid-specific	NULL
Oct2	NULL
transcription	NULL
factor	NULL
family	NULL
is	NULL
expressed	NULL
as	NULL
multiple	NULL
alternatively	NULL
spliced	NULL
isoforms	NULL
in	NULL
mouse	NULL
and	NULL
human	NULL
B-cells	NULL
.	NULL

All	NULL
the	NULL
isoforms	NULL
described	NULL
in	NULL
this	NULL
paper	NULL
retain	NULL
the	NULL
conserved	NULL
POU-domain	NULL
and	NULL
are	NULL
therefore	NULL
able	NULL
to	NULL
bind	NULL
specifically	NULL
to	NULL
the	NULL
cognate	NULL
octamer	NULL
motif	NULL
.	NULL

Furthermore	NULL
all	NULL
the	NULL
splicing	NULL
variants	NULL
retain	NULL
the	NULL
ability	NULL
to	NULL
activate	NULL
an	NULL
octamer	NULL
containing	NULL
promoter	NULL
in	NULL
a	NULL
cotransfection	NULL
assay	NULL
.	NULL

Our	NULL
analyses	NULL
also	NULL
show	NULL
that	NULL
the	NULL
pattern	NULL
of	NULL
alternative	NULL
splicing	NULL
is	NULL
conserved	NULL
throughout	NULL
the	NULL
murine	NULL
B-cell	NULL
lineage	NULL
and	NULL
probably	NULL
also	NULL
in	NULL
at	NULL
least	NULL
a	NULL
subset	NULL
of	NULL
T-lymphocytes	NULL
.	NULL

Multiplicity	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
The	NULL
octamer	NULL
motif	NULL
turns	NULL
out	NULL
to	NULL
be	NULL
a	NULL
multi-functional	NULL
regulatory	NULL
element	NULL
recognized	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
different	NULL
proteins	NULL
.	NULL

So	NULL
far	NULL
,	NULL
at	NULL
least	NULL
three	NULL
genes	NULL
encoding	NULL
octamer	NULL
binding	NULL
proteins	NULL
(	NULL
Oct1	NULL
,	NULL
Oct2	NULL
and	NULL
Oct4	NULL
)	NULL
have	NULL
been	NULL
cloned	NULL
(	NULL
17	NULL
,	NULL
24	NULL
,	NULL
27	NULL
,	NULL
28	NULL
,	NULL
29	NULL
,	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Additional	NULL
octamer	NULL
binding	NULL
proteins	NULL
have	NULL
been	NULL
identified	NULL
,	NULL
but	NULL
it	NULL
is	NULL
at	NULL
present	NULL
unclear	NULL
whether	NULL
they	NULL
are	NULL
encoded	NULL
by	NULL
separate	NULL
genes	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Multiple	NULL
genes	NULL
coding	NULL
for	NULL
distinct	NULL
transcription	NULL
factors	NULL
interacting	NULL
with	NULL
a	NULL
conserved	NULL
motif	NULL
have	NULL
been	NULL
described	NULL
for	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
CCAAT-box	NULL
,	NULL
the	NULL
AP-1	NULL
site	NULL
,	NULL
and	NULL
the	NULL
cAMP	NULL
response	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
(	NULL
44	NULL
,	NULL
45	NULL
,	NULL
46	NULL
,	NULL
47	NULL
,	NULL
48,49	NULL
)	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
alternative	NULL
splicing	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
generation	NULL
of	NULL
a	NULL
multitude	NULL
of	NULL
Oct2	NULL
isoforms	NULL
.	NULL

Preliminary	NULL
evidence	NULL
suggests	NULL
that	NULL
the	NULL
Oct4	NULL
gene	NULL
might	NULL
also	NULL
code	NULL
for	NULL
two	NULL
protein	NULL
isoforms	NULL
,	NULL
Octé4	NULL
and	NULL
OctS5	NULL
,	NULL
due	NULL
to	NULL
the	NULL
usage	NULL
of	NULL
alternate	NULL
translational	NULL
initiation	NULL
codons	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Alternative	NULL
splicing	NULL
as	NULL
a	NULL
mechanism	NULL
to	NULL
generate	NULL
multiple	NULL
isoforms	NULL
of	NULL
transcriptional	NULL
regulators	NULL
has	NULL
also	NULL
been	NULL
described	NULL
for	NULL
the	NULL
CTF/NF-I	NULL
transcription	NULL
factor	NULL
(	NULL
45	NULL
)	NULL
,	NULL
the	NULL
CREB	NULL
transcription	NULL
factor	NULL
(	NULL
50	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
for	NULL
the	NULL
drosophila	NULL
ultrabithorax	NULL
(	NULL
Ubx	NULL
)	NULL
gene	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Differential	NULL
activities	NULL
for	NULL
alternate	NULL
forms	NULL
have	NULL
been	NULL
desribed	NULL
for	NULL
both	NULL
CREB	NULL
and	NULL
CTF/NF-I	NULL
(	NULL
50	NULL
,	NULL
52	NULL
)	NULL
.	NULL

Another	NULL
striking	NULL
homology	NULL
between	NULL
the	NULL
CCAAT-box	NULL
and	NULL
octamer	NULL
binding	NULL
proteins	NULL
is	NULL
the	NULL
fact	NULL
that	NULL
members	NULL
of	NULL
either	NULL
family	NULL
can	NULL
function	NULL
in	NULL
stimulation	NULL
of	NULL
both	NULL
transcription	NULL
and	NULL
replication	NULL
(	NULL
52	NULL
,	NULL
53	NULL
)	NULL
.	NULL

Possible	NULL
functions	NULL
of	NULL
the	NULL
various	NULL
Oct2	NULL
isoforms	NULL
The	NULL
Oct2	NULL
transcription	NULL
factors	NULL
could	NULL
be	NULL
differentially	NULL
involved	NULL
in	NULL
several	NULL
aspects	NULL
during	NULL
B-cell	NULL
ontogeny	NULL
.	NULL

One	NULL
of	NULL
the	NULL
first	NULL
characteristics	NULL
of	NULL
a	NULL
committed	NULL
precursor	NULL
of	NULL
the	NULL
B-cell	NULL
lineage	NULL
is	NULL
the	NULL
transcription	NULL
of	NULL
unrearranged	NULL
heavy-chain	NULL
genes	NULL
(	NULL
sterile	NULL
g	NULL
transcription	NULL
)	NULL
.	NULL

It	NULL
has	NULL
recently	NULL
been	NULL
demonstrated	NULL
that	NULL
the	NULL
octamer	NULL
element	NULL
in	NULL
the	NULL
heavy-chain	NULL
enhancer	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
for	NULL
this	NULL
sterile	NULL
4	NULL
transcription	NULL
(	NULL
54	NULL
)	NULL
.	NULL

The	NULL
next	NULL
important	NULL
step	NULL
in	NULL
B-cell	NULL
development	NULL
is	NULL
the	NULL
rearrangement	NULL
of	NULL
the	NULL
heavy-chain	NULL
locus	NULL
.	NULL

Binding	NULL
of	NULL
Oct2	NULL
to	NULL
its	NULL
recognition	NULL
sites	NULL
in	NULL
the	NULL
heavy-chain	NULL
enhancer	NULL
and	NULL
the	NULL
Vp-promoters	NULL
could	NULL
be	NULL
a	NULL
critical	NULL
event	NULL
preceding	NULL
this	NULL
rearrangement	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
it	NULL
is	NULL
of	NULL
interest	NULL
that	NULL
the	NULL
Vy-promoters	NULL
contain	NULL
a	NULL
high-	NULL
and	NULL
a	NULL
low-affinity	NULL
binding	NULL
site	NULL
for	NULL
Oct2	NULL
,	NULL
the	NULL
octamer	NULL
and	NULL
the	NULL
heptamer	NULL
motif	NULL
(	NULL
55	NULL
,	NULL
56	NULL
)	NULL
,	NULL
and	NULL
Oct2	NULL
binding	NULL
to	NULL
these	NULL
two	NULL
sites	NULL
shows	NULL
cooperativity	NULL
(	NULL
43	NULL
,	NULL
57	NULL
)	NULL
.	NULL

Although	NULL
this	NULL
cooperative	NULL
binding	NULL
has	NULL
been	NULL
shown	NULL
in	NULL
vitro	NULL
using	NULL
purified	NULL
bacterially	NULL
expressed	NULL
Oct2	NULL
protein	NULL
corresponding	NULL
to	NULL
Oct2.2	NULL
(	NULL
43	NULL
)	NULL
it	NULL
is	NULL
not	NULL
known	NULL
what	NULL
type	NULL
of	NULL
Oct2	NULL
protein	NULL
binds	NULL
to	NULL
these	NULL
motifs	NULL
under	NULL
in	NULL
vivo	NULL
conditions	NULL
.	NULL

If	NULL
different	NULL
Oct2	NULL
isoforms	NULL
have	NULL
different	NULL
functions	NULL
during	NULL
B-cell	NULL
development	NULL
one	NULL
might	NULL
have	NULL
expected	NULL
to	NULL
observe	NULL
changes	NULL
in	NULL
the	NULL
Oct2	NULL
RNA	NULL
splicing	NULL
pattern	NULL
.	NULL

Although	NULL
our	NULL
analyses	NULL
clearly	NULL
show	NULL
that	NULL
this	NULL
is	NULL
not	NULL
the	NULL
case	NULL
,	NULL
this	NULL
does	NULL
not	NULL
exclude	NULL
functional	NULL
differences	NULL
of	NULL
the	NULL
various	NULL
isoforms	NULL
.	NULL

One	NULL
possibility	NULL
could	NULL
be	NULL
that	NULL
the	NULL
Oct2	NULL
isoforms	NULL
are	NULL
regulated	NULL
specifically	NULL
at	NULL
the	NULL
translational	NULL
level	NULL
.	NULL

Interestingly	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
GHF-1/Pit-1	NULL
protein	NULL
,	NULL
another	NULL
member	NULL
of	NULL
the	NULL
POU	NULL
domain	NULL
gene	NULL
family	NULL
,	NULL
has	NULL
been	NULL
suggested	NULL
to	NULL
be	NULL
regulated	NULL
at	NULL
the	NULL
translational	NULL
level	NULL
in	NULL
development	NULL
(	NULL
58	NULL
)	NULL
.	NULL

Differential	NULL
activation	NULL
properties	NULL
could	NULL
also	NULL
be	NULL
the	NULL
result	NULL
of	NULL
differential	NULL
modifications	NULL
of	NULL
the	NULL
various	NULL
isoforms	NULL
.	NULL

It	NULL
has	NULL
recently	NULL
been	NULL
reported	NULL
that	NULL
differential	NULL
phosphorylation	NULL
of	NULL
Octl	NULL
and	NULL
Oct2A	NULL
are	NULL
due	NULL
to	NULL
differences	NULL
at	NULL
the	NULL
carboxy	NULL
termini	NULL
of	NULL
the	NULL
two	NULL
proteins	NULL
and	NULL
that	NULL
these	NULL
differences	NULL
correlate	NULL
with	NULL
the	NULL
transactivation	NULL
potential	NULL
(	NULL
59	NULL
)	NULL
.	NULL

Members	NULL
of	NULL
the	NULL
Oct2	NULL
transcription	NULL
factor	NULL
family	NULL
might	NULL
also	NULL
be	NULL
recruited	NULL
for	NULL
specific	NULL
functions	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
specific	NULL
protein-protein	NULL
interactions	NULL
.	NULL

Interestingly	NULL
,	NULL
isoform	NULL
Oct2.4	NULL
is	NULL
devoid	NULL
of	NULL
a	NULL
functional	NULL
leucine	NULL
zipper	NULL
,	NULL
a	NULL
structure	NULL
that	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
protein-protein	NULL
interactions	NULL
(	NULL
60	NULL
,	NULL
61	NULL
,	NULL
62,63	NULL
)	NULL
.	NULL

This	NULL
model	NULL
has	NULL
been	NULL
suggested	NULL
to	NULL
explain	NULL
the	NULL
differential	NULL
activities	NULL
of	NULL
the	NULL
Octl	NULL
and	NULL
Oct2	NULL
proteins	NULL
which	NULL
are	NULL
coexpressed	NULL
in	NULL
lymphoid	NULL
cells	NULL
(	NULL
64	NULL
)	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
all	NULL
the	NULL
various	NULL
Oct2	NULL
isoforms	NULL
stimulate	NULL
an	NULL
octamer	NULL
containing	NULL
promoter	NULL
in	NULL
a	NULL
cotransfection	NULL
assay	NULL
shows	NULL
that	NULL
all	NULL
the	NULL
variants	NULL
could	NULL
be	NULL
functional	NULL
transcription	NULL
factors	NULL
.	NULL

This	NULL
result	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
mutational	NULL
analyses	NULL
of	NULL
the	NULL
Oct2A	NULL
(	NULL
Oct2.1	NULL
and	NULL
Oct2.2	NULL
,	NULL
respectively	NULL
)	NULL
protein	NULL
(	NULL
65	NULL
,	NULL
66	NULL
)	NULL
which	NULL
indicates	NULL
that	NULL
deletion	NULL
of	NULL
either	NULL
the	NULL
region	NULL
on	NULL
the	NULL
amino-	NULL
or	NULL
carboxy-terminal	NULL
site	NULL
of	NULL
the	NULL
POU	NULL
domain	NULL
does	NULL
not	NULL
significantly	NULL
affect	NULL
the	NULL
transactivation	NULL
function	NULL
.	NULL

While	NULL
this	NULL
manuscript	NULL
was	NULL
in	NULL
preparation	NULL
,	NULL
Hatzopoulos	NULL
and	NULL
colleagues	NULL
published	NULL
the	NULL
cloning	NULL
of	NULL
a	NULL
cDNA	NULL
encoding	NULL
mouse	NULL
Oct2B	NULL
(	NULL
67	NULL
)	NULL
.	NULL

Their	NULL
cDNA	NULL
is	NULL
essentially	NULL
identical	NULL
to	NULL
our	NULL
Oct2.5	NULL
cDNA	NULL
supporting	NULL
the	NULL
conclusion	NULL
drawn	NULL
in	NULL
this	NULL
paper	NULL
.	NULL

ACKNOWLEDGEMENTS	NULL
We	NULL
would	NULL
like	NULL
to	NULL
thank	NULL
P.	NULL
Nielson	NULL
for	NULL
the	NULL
pre	NULL
B-cell	NULL
cDNA	NULL
library	NULL
,	NULL
A.	NULL
Poustka	NULL
for	NULL
the	NULL
genomic	NULL
cosmid	NULL
library	NULL
,	NULL
H.	NULL
Kraft-Czepa	NULL
and	NULL
P.	NULL
Krammer	NULL
for	NULL
the	NULL
pExNeo	NULL
eucaryotic	NULL
expression	NULL
vector	NULL
,	NULL
H-R.	NULL
Kiefer	NULL
for	NULL
the	NULL
preparation	NULL
of	NULL
oligonucleotides	NULL
used	NULL
in	NULL
the	NULL
initial	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
Oct2	NULL
cDNAs	NULL
,	NULL
E.	NULL
Schreiber	NULL
for	NULL
communicating	NULL
unpublished	NULL
results	NULL
,	NULL
R.	NULL
Pollwein	NULL
,	NULL
R.	NULL
Herrera	NULL
,	NULL
C.	NULL
Ullmer	NULL
and	NULL
T.	NULL
Lernbecher	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
G.P	NULL
.	NULL

Wee	NULL
for	NULL
help	NULL
in	NULL
preparing	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
BMFT	NULL
.	NULL

The	NULL
Basel	NULL
Institute	NULL
for	NULL
Immunology	NULL
was	NULL
founded	NULL
and	NULL
is	NULL
supported	NULL
by	NULL
F.	NULL
Hoffmann-La	NULL
Roche	NULL
Co.	NULL
Ltd.	NULL
,	NULL
CH-4005	NULL
Basel	NULL
,	NULL
Switzerland	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Bergman	NULL
,	NULL
Y.	NULL
,	NULL
Rice	NULL
,	NULL
D.	NULL
,	NULL
Grosschedl	NULL
,	NULL
R.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1984	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
81	NULL
,	NULL
7041-7045.	NULL
.	NULL

Mason	NULL
,	NULL
J.0	NULL
.	NULL

,	NULL
Williams	NULL
,	NULL
G.T	NULL
.	NULL

&	NULL
Neuberger	NULL
,	NULL
M.S	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Cell	NULL
41	NULL
,	NULL
479-487.	NULL
.	NULL

Grosschedl	NULL
,	NULL
R.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1985	NULL
)	NULL
Cell	NULL
41	NULL
,	NULL
885-897.	NULL
.	NULL

Picard	NULL
,	NULL
D.	NULL
&	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1985	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

4	NULL
,	NULL
2831-2838.	NULL
.	NULL

Parslow	NULL
,	NULL
T.G	NULL
.	NULL

,	NULL
Blair	NULL
,	NULL
D.L	NULL
.	NULL

,	NULL
Murphy	NULL
,	NULL
W.J	NULL
.	NULL

&	NULL
Granner	NULL
,	NULL
D.K	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
81	NULL
,	NULL
2650-2654.	NULL
.	NULL

Falkner	NULL
,	NULL
F.G.	NULL
&	NULL
Zachau	NULL
,	NULL
H.G	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Nature	NULL
310	NULL
,	NULL
71-74	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
,	NULL
Pierce	NULL
,	NULL
J.W	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
236	NULL
,	NULL
1573-1577.	NULL
.	NULL

Dreyfus	NULL
,	NULL
M.	NULL
,	NULL
Doyen	NULL
,	NULL
N.	NULL
&	NULL
Rougeon	NULL
,	NULL
F.	NULL
(	NULL
1987	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

6	NULL
,	NULL
1685-1690.	NULL
.	NULL

Gerster	NULL
,	NULL
T.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Thali	NULL
,	NULL
M.	NULL
,	NULL
Jirieny	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1987	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

6	NULL
,	NULL
1323-1330	NULL
.	NULL

10	NULL
.	NULL

Wirth	NULL
,	NULL
T.	NULL
,	NULL
Staudt	NULL
,	NULL
L.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
329	NULL
,	NULL
174-178	NULL
.	NULL

11	NULL
.	NULL

LaBella	NULL
,	NULL
F.	NULL
,	NULL
Sive	NULL
,	NULL
H.L	NULL
.	NULL

,	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

&	NULL
Heintz	NULL
,	NULL
N.	NULL
(	NULL
1988	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

2	NULL
,	NULL
32-39	NULL
.	NULL

12	NULL
.	NULL

Mattaj	NULL
,	NULL
L.	NULL
W.	NULL
,	NULL
Lienhard	NULL
,	NULL
S.	NULL
,	NULL
Jirieny	NULL
,	NULL
J	NULL
.	NULL

&	NULL
DeRobertis	NULL
,	NULL
E.M.	NULL
(	NULL
1985	NULL
)	NULL
Nature	NULL
316	NULL
,	NULL
163-167	NULL
.	NULL

13	NULL
.	NULL

Carbon	NULL
,	NULL
P.	NULL
,	NULL
Murgo	NULL
,	NULL
S.	NULL
,	NULL
Ebel	NULL
,	NULL
J.	NULL
,	NULL
Krol	NULL
,	NULL
A.	NULL
,	NULL
Tebb	NULL
,	NULL
G.	NULL
&	NULL
Mattaj	NULL
,	NULL
LW	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Cell	NULL
51	NULL
,	NULL
71-79	NULL
.	NULL

14	NULL
.	NULL

Pruijn	NULL
,	NULL
G.J.M	NULL
.	NULL

,	NULL
van	NULL
Driel	NULL
,	NULL
W.	NULL
&	NULL
van	NULL
der	NULL
Vliet	NULL
,	NULL
P.C	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Nature	NULL
322	NULL
,	NULL
656-659	NULL
.	NULL

15	NULL
.	NULL

Singh	NULL
,	NULL
H.	NULL
,	NULL
Sen	NULL
,	NULL
R.	NULL
,	NULL
Baltimore	NULL
,	NULL
D.	NULL
&	NULL
Sharp	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Nature	NULL
319	NULL
,	NULL
154-158	NULL
.	NULL

16	NULL
.	NULL

Fletcher	NULL
,	NULL
C.	NULL
,	NULL
Heintz	NULL
,	NULL
N.	NULL
&	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Cell	NULL
51	NULL
,	NULL
773-781	NULL
.	NULL

17	NULL
.	NULL

Sturm	NULL
,	NULL
R.A.	NULL
,	NULL
Das	NULL
,	NULL
G.	NULL
&	NULL
Herr	NULL
,	NULL
W.	NULL
(	NULL
1988	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

2	NULL
,	NULL
1582-1599	NULL
.	NULL

18	NULL
.	NULL

O'Neill	NULL
,	NULL
EA	NULL
.	NULL

,	NULL
Fletcher	NULL
,	NULL
C.	NULL
,	NULL
Burrow	NULL
,	NULL
C.R	NULL
.	NULL

,	NULL
Heintz	NULL
,	NULL
N.	NULL
,	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

&	NULL
Kelly	NULL
,	NULL
T.J.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
241	NULL
,	NULL
1210-1213	NULL
.	NULL

19	NULL
.	NULL

Staudt	NULL
,	NULL
LM	NULL
.	NULL

,	NULL
Singh	NULL
,	NULL
H.	NULL
,	NULL
Sen	NULL
,	NULL
R.	NULL
,	NULL
Wirth	NULL
,	NULL
T.	NULL
,	NULL
Sharp	NULL
,	NULL
P.A	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Nature	NULL
323	NULL
,	NULL
640-643	NULL
.	NULL

20	NULL
.	NULL

Landolfi	NULL
,	NULL
N.F	NULL
.	NULL

,	NULL
Capra	NULL
,	NULL
J.D	NULL
.	NULL

&	NULL
Tucker	NULL
,	NULL
P.W	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Nature	NULL
323	NULL
,	NULL
548-551	NULL
.	NULL

21	NULL
.	NULL

Scheidereit	NULL
,	NULL
C.	NULL
,	NULL
Heguy	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Cell	NULL
51	NULL
,	NULL
783-793	NULL
.	NULL

22	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Miiller	NULL
,	NULL
M.M	NULL
.	NULL

&	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1988	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

7	NULL
,	NULL
4221-4229	NULL
.	NULL

23	NULL
.	NULL

Scholer	NULL
,	NULL
H.R	NULL
.	NULL

,	NULL
Hatzopoulos	NULL
,	NULL
A.K	NULL
.	NULL

,	NULL
Balling	NULL
,	NULL
R.	NULL
,	NULL
Suzuki	NULL
,	NULL
N.	NULL
&	NULL
Gruss	NULL
,	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
2543-2550	NULL
.	NULL

24	NULL
.	NULL

Okamoto	NULL
,	NULL
K.	NULL
,	NULL
Okazawa	NULL
,	NULL
H.	NULL
,	NULL
Okuda	NULL
,	NULL
A.	NULL
,	NULL
Sakai	NULL
,	NULL
M.	NULL
,	NULL
Muramatsu	NULL
,	NULL
M.	NULL
&	NULL
Hamada	NULL
,	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
60	NULL
,	NULL
461-472	NULL
.	NULL

25	NULL
.	NULL

Cox	NULL
,	NULL
P.M.	NULL
,	NULL
Temperley	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
Kumar	NULL
,	NULL
H.	NULL
&	NULL
Goding	NULL
,	NULL
C.R	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Nuc	NULL
.	NULL

Acids	NULL
Res	NULL
.	NULL

16	NULL
,	NULL
11047-11056	NULL
.	NULL

26	NULL
.	NULL

Barberis	NULL
,	NULL
A.	NULL
,	NULL
Superti-Furga	NULL
,	NULL
G.	NULL
&	NULL
Busslinger	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
50	NULL
,	NULL
347-359	NULL
.	NULL

27	NULL
.	NULL

Staudt	NULL
,	NULL
LM	NULL
.	NULL

,	NULL
Clerc	NULL
,	NULL
R.G	NULL
.	NULL

,	NULL
Singh	NULL
,	NULL
H.	NULL
,	NULL
LeBowitz	NULL
,	NULL
J.H	NULL
.	NULL

,	NULL
Sharp	NULL
,	NULL
P.A	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
241	NULL
,	NULL
577-580	NULL
.	NULL

Ui	NULL
B	NULL
w	NULL
b	NULL
\	NULL
co	NULL
=1	NULL
on	NULL
28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59.	NULL
.	NULL

Landschulz	NULL
,	NULL
W.H	NULL
.	NULL

,	NULL
Johnson	NULL
,	NULL
P.F	NULL
.	NULL

&	NULL
McKnight	NULL
,	NULL
S.L	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Science	NULL
243	NULL
,	NULL
61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

1	NULL
51	NULL
Miiller	NULL
,	NULL
M.M	NULL
.	NULL

,	NULL
Ruppert	NULL
,	NULL
S.	NULL
,	NULL
Schaffner	NULL
,	NULL
W.	NULL
&	NULL
Matthias	NULL
,	NULL
P.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
336	NULL
,	NULL
544-551	NULL
.	NULL

Scheidereit	NULL
,	NULL
C.	NULL
,	NULL
Cromlish	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
Gerster	NULL
,	NULL
T.	NULL
,	NULL
Kawakami	NULL
,	NULL
K.	NULL
,	NULL
Balmaceda	NULL
,	NULL
C.-G.	NULL
,	NULL
Currie	NULL
,	NULL
R.A.	NULL
&	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Nature	NULL
336	NULL
,	NULL
551-557	NULL
.	NULL

Scholer	NULL
,	NULL
H.R	NULL
.	NULL

,	NULL
Ruppert	NULL
,	NULL
S.	NULL
,	NULL
Suzuki	NULL
,	NULL
N.	NULL
,	NULL
Chowdhury	NULL
,	NULL
K.	NULL
&	NULL
P.	NULL
Gruss	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Nature	NULL
344	NULL
,	NULL
435-439	NULL
.	NULL

Rosner	NULL
,	NULL
M.H	NULL
.	NULL

,	NULL
Vigano	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
Ozato	NULL
,	NULL
K.	NULL
,	NULL
Timmons	NULL
,	NULL
P.M.	NULL
,	NULL
Poirier	NULL
,	NULL
F.	NULL
,	NULL
Rigby	NULL
,	NULL
P.W.J	NULL
.	NULL

&	NULL
Staudt	NULL
,	NULL
L.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
345	NULL
,	NULL
686-692	NULL
.	NULL

Herr	NULL
,	NULL
W.	NULL
,	NULL
Sturm	NULL
,	NULL
R.A.	NULL
,	NULL
Clerc	NULL
,	NULL
R.G	NULL
.	NULL

,	NULL
Corcoran	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Baltimore	NULL
,	NULL
D.	NULL
,	NULL
Sharp	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
Ingraham	NULL
,	NULL
H.A	NULL
.	NULL

,	NULL
Rosenfeld	NULL
,	NULL
M.G	NULL
.	NULL

,	NULL
Finney	NULL
,	NULL
M.	NULL
,	NULL
Ruvkun	NULL
,	NULL
G.	NULL
&	NULL
Horvitz	NULL
,	NULL
HR	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

2	NULL
,	NULL
1513-1516.	NULL
.	NULL

He	NULL
,	NULL
X.	NULL
,	NULL
Treacy	NULL
,	NULL
M.N	NULL
.	NULL

,	NULL
Simmons	NULL
,	NULL
D.M	NULL
.	NULL

,	NULL
Ingraham	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
Swanson	NULL
,	NULL
L.	NULL
W.	NULL
&	NULL
Rosenfeld	NULL
,	NULL
M.G	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Nature	NULL
340	NULL
,	NULL
35-42.	NULL
.	NULL

Sturm	NULL
,	NULL
R.A.	NULL
&	NULL
Herr	NULL
,	NULL
W.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
336	NULL
,	NULL
601604.	NULL
.	NULL

Stern	NULL
,	NULL
S.	NULL
,	NULL
Tanaka	NULL
,	NULL
M.	NULL
&	NULL
Herr	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
341	NULL
,	NULL
624-630.	NULL
.	NULL

Kristie	NULL
,	NULL
TM	NULL
.	NULL

,	NULL
LeBowitz	NULL
,	NULL
J.H	NULL
.	NULL

&	NULL
Sharp	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
4229-4238.	NULL
.	NULL

Ingraham	NULL
,	NULL
H.A	NULL
.	NULL

,	NULL
Flynn	NULL
,	NULL
S.E	NULL
.	NULL

,	NULL
Voss	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Albert	NULL
,	NULL
V.R	NULL
.	NULL

,	NULL
Kapiloff	NULL
,	NULL
M.S	NULL
.	NULL

,	NULL
Wilson	NULL
,	NULL
L.	NULL
&	NULL
Rosenfeld	NULL
,	NULL
M.G	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
1021-1033	NULL
.	NULL

Clerc	NULL
,	NULL
R.G	NULL
.	NULL

,	NULL
Corcoran	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
LeBowitz	NULL
,	NULL
J.H	NULL
.	NULL

,	NULL
Baltimore	NULL
,	NULL
D.	NULL
&	NULL
Sharp	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

2	NULL
,	NULL
1570-1581	NULL
.	NULL

Wirth	NULL
,	NULL
T.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

7	NULL
,	NULL
3109-3113.	NULL
.	NULL

Ausubel	NULL
,	NULL
FM	NULL
.	NULL

,	NULL
Brent	NULL
,	NULL
R.	NULL
,	NULL
Kingston	NULL
,	NULL
R.E	NULL
.	NULL

,	NULL
Moore	NULL
,	NULL
D.D	NULL
.	NULL

,	NULL
Seidman	NULL
,	NULL
J.G	NULL
.	NULL

,	NULL
Smith	NULL
,	NULL
J.A	NULL
.	NULL

&	NULL
Struhl	NULL
,	NULL
K.	NULL
Current	NULL
protocols	NULL
in	NULL
molecular	NULL
biology	NULL
(	NULL
John	NULL
Wiley	NULL
&	NULL
Sons	NULL
,	NULL
New	NULL
York	NULL
,	NULL
Chichester	NULL
,	NULL
Brisbane	NULL
,	NULL
Toronto	NULL
,	NULL
Singapore	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

Dignam	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
Lebovitz	NULL
,	NULL
R.M	NULL
.	NULL

&	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
.	NULL

Harlow	NULL
,	NULL
E.	NULL
&	NULL
Lane	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Antibodies	NULL
:	NULL
A	NULL
laboratory	NULL
manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
LeBowitz	NULL
,	NULL
J.H	NULL
.	NULL

,	NULL
Clerc	NULL
,	NULL
R.G	NULL
.	NULL

,	NULL
Brenowitz	NULL
,	NULL
M.	NULL
&	NULL
Sharp	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

3	NULL
,	NULL
1625-1638.	NULL
.	NULL

Landschulz	NULL
,	NULL
W.H	NULL
.	NULL

,	NULL
Johnson	NULL
,	NULL
P.F	NULL
.	NULL

,	NULL
Adashi	NULL
,	NULL
E.Y	NULL
.	NULL

,	NULL
Graves	NULL
,	NULL
B.J	NULL
.	NULL

&	NULL
McKnight	NULL
,	NULL
S.L	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

2	NULL
,	NULL
786-800	NULL
.	NULL

Santoro	NULL
,	NULL
C.	NULL
,	NULL
Mermod	NULL
,	NULL
N.	NULL
,	NULL
Andrews	NULL
,	NULL
P.C	NULL
.	NULL

&	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
334	NULL
,	NULL
218-224.	NULL
.	NULL

Gil	NULL
,	NULL
G.	NULL
,	NULL
Smith	NULL
,	NULL
J.R.	NULL
,	NULL
Goldstein	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
Slaughter	NULL
,	NULL
C.A	NULL
.	NULL

,	NULL
Orth	NULL
,	NULL
K.	NULL
,	NULL
Brown	NULL
,	NULL
M.S	NULL
.	NULL

&	NULL
Osbomne	NULL
,	NULL
TF	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85	NULL
,	NULL
8963-8967	NULL
.	NULL

Zerial	NULL
,	NULL
M.	NULL
,	NULL
Toschi	NULL
,	NULL
L.	NULL
,	NULL
Ryseck	NULL
,	NULL
R.-P.	NULL
,	NULL
Schuermann	NULL
,	NULL
M.	NULL
,	NULL
Miiller	NULL
,	NULL
R.	NULL
&	NULL
Bravo	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
805-813	NULL
.	NULL

Ryder	NULL
,	NULL
K.	NULL
,	NULL
Lau	NULL
,	NULL
L.F.	NULL
&	NULL
Nathans	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85	NULL
,	NULL
1487-1491	NULL
.	NULL

Hai	NULL
,	NULL
T.	NULL
,	NULL
Liu	NULL
,	NULL
F.	NULL
,	NULL
Coukos	NULL
,	NULL
W.J	NULL
.	NULL

&	NULL
Green	NULL
,	NULL
MR.	NULL
(	NULL
1989	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

3	NULL
,	NULL
2083-2090	NULL
.	NULL

Yamamoto	NULL
,	NULL
K.K	NULL
.	NULL

,	NULL
Gonzalez	NULL
,	NULL
G.A	NULL
.	NULL

,	NULL
Menzel	NULL
,	NULL
P.	NULL
,	NULL
Rivier	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Montminy	NULL
,	NULL
MR.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
60	NULL
,	NULL
611-617	NULL
.	NULL

O'Connor	NULL
,	NULL
M.B	NULL
.	NULL

,	NULL
Binari	NULL
,	NULL
R.	NULL
,	NULL
Perkins	NULL
,	NULL
L.A.	NULL
&	NULL
Bender	NULL
,	NULL
W.	NULL
(	NULL
1988	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

7	NULL
,	NULL
435-445	NULL
.	NULL

Mermod	NULL
,	NULL
N.	NULL
,	NULL
O'Neill	NULL
,	NULL
E.A	NULL
.	NULL

,	NULL
Kelly	NULL
,	NULL
T.J.	NULL
&	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
741-753	NULL
.	NULL

Verrijzer	NULL
,	NULL
C.P	NULL
.	NULL

,	NULL
Kal	NULL
,	NULL
A.J	NULL
.	NULL

&	NULL
Van	NULL
der	NULL
Vliet	NULL
,	NULL
P.C	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
1883-1888.	NULL
.	NULL

Su	NULL
,	NULL
L.-K.	NULL
&	NULL
Kadesch	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
2619-2624.	NULL
.	NULL

Poellinger	NULL
,	NULL
L.	NULL
&	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
747-756	NULL
.	NULL

56	NULL
.	NULL

Kemler	NULL
,	NULL
I.	NULL
,	NULL
Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Miiller	NULL
,	NULL
M.M	NULL
.	NULL

,	NULL
Matthias	NULL
,	NULL
P.	NULL
&	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
2001-2008	NULL
.	NULL

Poellinger	NULL
,	NULL
L.	NULL
,	NULL
Yoza	NULL
,	NULL
B.K	NULL
.	NULL

&	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Nature	NULL
337	NULL
,	NULL
573-576	NULL
.	NULL

Dollé	NULL
,	NULL
P.	NULL
,	NULL
Castrillo	NULL
,	NULL
J.-L.	NULL
,	NULL
Theill	NULL
,	NULL
L.E	NULL
.	NULL

,	NULL
Deerinck	NULL
,	NULL
T.	NULL
,	NULL
Ellisman	NULL
,	NULL
M.	NULL
&	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
60	NULL
,	NULL
809-820	NULL
.	NULL

Tanaka	NULL
,	NULL
M.	NULL
&	NULL
Herr	NULL
,	NULL
W.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
60	NULL
,	NULL
375-386	NULL
.	NULL

1681-1688	NULL
.	NULL

Schuermann	NULL
,	NULL
M.	NULL
,	NULL
Neuberg	NULL
,	NULL
M.	NULL
,	NULL
Hunter	NULL
,	NULL
J.B.	NULL
,	NULL
Jenuwein	NULL
,	NULL
T.	NULL
,	NULL
Ryseck	NULL
,	NULL
R.-P.	NULL
,	NULL
Bravo	NULL
,	NULL
R.	NULL
&	NULL
Miiller	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
56	NULL
,	NULL
507-516	NULL
.	NULL

Turner	NULL
,	NULL
R.	NULL
&	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
243	NULL
,	NULL
1989-1694	NULL
.	NULL

Gentz	NULL
,	NULL
R.	NULL
,	NULL
Rauscher	NULL
III	NULL
,	NULL
F.J.	NULL
,	NULL
Abate	NULL
,	NULL
C.	NULL
&	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
243	NULL
,	NULL
1695-1699.	NULL
.	NULL

Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Trends	NULL
Genetics	NULL
5	NULL
,	NULL
37-39.	NULL
.	NULL

Gerster	NULL
,	NULL
T.	NULL
,	NULL
Balmaceda	NULL
,	NULL
C.	NULL
&	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
1635-1643.	NULL
.	NULL

Miiller-Immergliick	NULL
,	NULL
M.M	NULL
.	NULL

,	NULL
Schaffner	NULL
,	NULL
W.	NULL
&	NULL
Matthias	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
1625-1634.	NULL
.	NULL

Hatzopoulos	NULL
,	NULL
A.K	NULL
.	NULL

,	NULL
Stoykova	NULL
,	NULL
A.S.	NULL
,	NULL
Erselius	NULL
,	NULL
J.R.	NULL
,	NULL
Goulding	NULL
,	NULL
M.	NULL
,	NULL
Neuman	NULL
,	NULL
T.	NULL
&	NULL
Gruss	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Development	NULL
109	NULL
,	NULL
349-362	NULL
.	NULL

